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ABSTRACT 
Protozoan infections such as Malaria, Leishmaniasis, Toxoplasmosis, Chaga’s disease and 
African trypanosomiasis caused by the Plasmodium, Leishmania, Toxoplasma and Trypanosoma 
genuses respectively; inflict a huge economic, health and social impact in endemic regions 
particularly tropical and sub-tropical regions. The combined infections are estimated at over a 
billion annually and approximately 1.1 million deaths annually. The global burden of the 
protozoan infections is worsened by the increased drug resistance, toxicity and the relatively high 
cost of treatment and prophylaxis. Therefore there has been a high demand for new drugs and 
drug targets that play a role in parasite virulence. Cysteine proteases have been validated as 
viable drug targets due to their role in the infectivity stage of the parasites within the human host. 
There is a variety of cysteine proteases hence they are subdivided into families and in this study 
we focus on the clan CA, papain family C1 proteases. The current inhibitors for the protozoan 
cysteine proteases lack selectivity and specificity which contributes to drug toxicity. Therefore 
there is a need to identify the differences and similarities between the host, vector and protozoan 
proteases. This study uses a variety of bioinformatics tools to assess these differences and 
similarities. The Plasmodium cysteine protease FP-2 is the most characterized protease hence it 
was used as a reference to all the other proteases and its homologs were retrieved, aligned and 
the evolutionary relationships established. The homologs were also analysed for common motifs 
and the physicochemical properties determined which were validated using the Kruskal-Wallis 
test. These analyses revealed that the host and vector cathepsins share similar properties while 
the parasite cathepsins differ. At sub-site level sub-site 2 showed greater variations suggesting 
diverse ligand specificity within the proteases, a revelation that is vital in the design of anti-
protozoan inhibitors. 
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   CHAPTER ONE 
1. INTRODUCTION 
 
1.1 PROTOZOAN PARASITES AND INFECTIONS  
Protozoa are defined as microscopic organisms that possess animal-like features and exist as 
independent single cells (McKerrow et al. 2006). Their infections cause a substantial amount of 
human morbidity and mortality. The total number of deaths posed by the protozoan infections is 
estimated at around a million annually (Andrews et al. 2014). This study focuses on five major 
protozoan infections namely Malaria, Toxoplasmosis, Chaga’s disease, Leishmaniasis and 
African trypanosomiasis. The spread of these infections requires transmission by vectors and in 
some cases intermediate hosts (Table 1.1). 
Table 1.1 A summary of the protozoan infections of interest in this study showing their respective vectors and 
responsible protozoan parasites. 
Protozoa Protozoa parasite Vector 
Malaria Plasmodium spp. Female anopheles 
mosquito 
Leishmaniasis Leishmania spp. Female sand fly 
African 
Trypanosomiasis 
Trypanosoma 
brucei 
Tsetse fly 
Chaga’s disease Trypanosoma cruzi Triatomine bug 
Toxoplasmosis Toxoplasma gondii Contaminated  meat 
and feline contact 
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The World Health Organization (WHO) states that approximately 50 % of the global population 
suffers from one parasitic infection or another (World Health Organization, 2010). This chapter 
will focus on the above infections and summarize their epidemiology, parasite lifecycle, 
diagnosis and treatment as well as their current treatment and drug targets. 
1.1.1 MALARIA 
Malaria is the most fatal of all protozoan infections which threatens about 3.3 billion lives 
resulting in ~0.6 – 1.1 million deaths yearly (Murray et al. 2013). The disease is caused by the 
Plasmodium genus namely; P. falciparum being the most severe and fatal type, P. vivax, P.ovale, 
P.knowlesi and lastly P.Malariae (Mharakurwa et al. 2012). A majority of Malaria infections and 
deaths are caused by P. falciparum and P. vivax infections in both children and adults (World 
Health Organization 2013). P.falciparum is an epidemic in sub-Saharan Africa, while P. vivax 
causes a huge amount of morbidity particularly in the Asia-Pacific and South-American regions 
(Murray et al. 2013). 
The Plasmodium parasites are spread by the female anopheles mosquito through an infective bite 
of the Malaria-infected female anopheles mosquito which inoculates the sporozoites either into 
the subcutaneous tissue or into the bloodstream during a blood meal (Korde et al. 2008). Almost 
immediately the sporozoites infect the liver cells. Here they gradually mature into schizonts 
which eventually disrupt and release merozoites (Lecaille et al. 2002) (Figure 1.1). The P.vivax 
and P.ovale species in particular may have a dormant stage (hypnozoites) that lingers in the liver 
resulting in relapses by invading the bloodstream weeks, or even years later (Collins & Jeffery 
2007). 
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Figure 1.1 An illustration of the Plasmodium lifecycle within the human blood stream and the female anopheles 
mosquito. The drawing was adapted from (http://www.dw.de) webpage and edited accordingly. 
As the concentration of the parasite increases in the blood stream the clinical symptoms such as 
headaches, shaking chills and tiredness are manifested (Autino et al. 2012). The symptoms are 
used as a basis for diagnosis. However this is a challenging method since the Malaria symptoms 
are non-specific and there is a substantial overlap with other diseases (Tangpukdee et al. 2009). 
This results in the over-treatment of Malaria or non-treatment of other diseases in Malaria-
endemic regions, and misdiagnosis in non-endemic areas. Therefore to increase the efficiency of 
the diagnosis procedure the clinical methods are coupled with laboratory methods. The 
laboratory diagnosis involves the identification of the Malaria parasites in the patients’ blood 
through microscopy (Tangpukdee et al. 2009). 
1.1.2 AFRICAN TRYPANOSOMIASIS 
This is also commonly known as African sleeping sickness caused by the Trypanosoma genus. 
There are two forms of the disease found in West and East Africa caused by the Trypanosoma 
brucei gambiense and Trypanosoma brucei rhodesiense, respectively (Chappuis et al. 2005).  
The African sleeping sickness threatens the lives of approximately 60 million people in Sub-
Saharan Africa. This threat is spread by the tsetse fly (Barrett et al. 2003). The parasite is 
transmitted when the infected insect takes a blood meal and secretes the parasite from its salivary 
gland into the human blood stream (Malvy & Chappuis 2011) (Figure 1.2). 
18 
 
 
Figure 1.2 A diagrammatic illustration of the lifecycle of Trypanosoma brucei within the human host and its tsetse 
fly vector. The drawing was adapted from (http://www.who.int) and edited accordingly. 
The trypomastigotes injected into the blood stream during the fly’s blood meal multiply in the 
blood, spinal fluid and the lymph fluid. The symptoms are manifested as a consequence of the 
presence of trypomastigotes in these body fluids particularly in the blood (Enanga et al. 2002). 
The symptoms include fever, arthralgia, headache, and malaise in the hemolymphatic stage and 
motor and sensory disorders, endocrine disorders and weight loss in the advanced Central 
Nervous System (CNS) stage (Barrett et al. 2003). The diagnosis of the disease involves straight 
forward microscopy of the lymph and spinal fluid specimens (Chappuis et al. 2005).  
1.1.3 CHAGA’S DISEASE 
Chaga’s disease is caused by a Trypanosoma cruzi infection. It is primarily found in the United 
States, Latin America and Mexico. Approximately 8-10 million people are reported to be 
infected by the parasite annually (Rassi Jr et al. 2010). The prevalence of the disease is 
exacerbated by the kissing bug which transmits Trypanosoma cruzi. The insect infects the host 
by secreting on the host through a blood meal and then defecates on the host. The secretions 
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cause the host to itch; the scratching forms microabrasions through which the trypomastigotes in 
the faeces enter the host. The parasite then moves to the blood and lymph systems where it 
multiplies (Barrett et al. 2003) (Figure 1.3). 
 
Figure 1.3 An illustration of the Trypanosoma cruzi lifecycle showing the human and triatomine bug stages. The 
diagram was adapted from the (http://www.who.int/disease/Chagas/lifecycle) and edited accordingly. 
Chaga’s disease primarily affects the spine and the heart. The initial stage is acute and involves 
symptoms such as malaise, anorexia, fever, vomiting and diarrhoea. The acute initial stage is 
followed by a chronic infection that usually leads to neurological disorders (Kirchhoff 2011). 
The acute phase is usually misdiagnosed unlike the chronic phase which is usually diagnosed 
through direct observation of the trypomastigotes in the patients’ blood smear (Antunes et al. 
2002).  
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1.1.4 LEISHMANIASIS 
Leishmaniasis is caused by the Leishmania species that are intracellular organisms that cause 
three major disorders in humans namely mucocutaneous Leishmaniasis, visceral Leishmaniasis 
and cutaneous Leishmaniasis; all have varying immunopathologies hence pose different degrees 
of mortality and morbidity (Andrews et al. 2014).  
There are approximately 12 million estimated infections of Leishmaniasis globally and the 
associated deaths are estimated at 50 000 annually (Delgado et al. 2008). Approximately 500 000 
infections are reported to be cases of visceral Leishmaniasis and 1.5 million of cutaneous 
Leishmaniasis (Alvar et al. 2012). 
The parasite is transmitted by the Phlebotomine sand fly, through an infective bite of the insect. 
During the blood meal the infected sand fly injects the promastigotes into the uninfected human; 
the promastigotes are then phagocytosed by macrophages. Within this phagolysome the parasites 
multiply and destroy the host cell (Wittner & Tanowitz 2000) (Figure 1.4). 
 
Figure 1.4 A diagrammatic illustration of the Leishmania lifecycle in both sand fly and human stages. The diagram 
was adapted from (http://www.who.int) webpage and edited accordingly. 
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Currently Leishmaniasis is diagonised using real-time PCR assays, immunoassays, and 
microscopy and culture systems (Singh & Sivakumar 2003). The microscopy method is preferred 
in diagonosing Leishmaniasis. The specimens from patients are stained and the Leishmania 
parasite is identified through direct microscopy (Rosenblatt 2009). In some cases microscopy 
maybe unrealistic hence serological tests such as the dipstick test maybe used. The dipstick tests 
are rapid, sensitive and inexpensive (Rosenblatt 2009).  
1.1.5 TOXOPLASMOSIS 
Toxoplasma gondii is the intracellular protozoan that causes Toxoplasmosis. The disease has a 
global epidemiology and affects about 25–30% of the global population (Montoya & Liesenfeld 
2004). It is usually transmitted through the ingestion of meat contaminated with tissue cysts such 
as pork or ingestion of oocysts shed by household cats. The parasite can also be transmitted from 
mother to child resulting in foetal death or birth defects (Montoya & Liesenfeld 2004). The 
parasite is resistant to the immune system (Dubey 2009). The resistant structures allow the 
parasite to mature within the host resulting in the eventual rupture of the tissue cysts thus 
releasing the tachyzoite form of the parasite that infects new host cells (Weiss & Dubey 2009) 
(Figure 1.5). 
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Figure 1.5 An illustration of the transmission and lifecycle of the Toxoplasma parasite within the hosts and vectors. 
The images were adapted from (http://www.scielo.br) and (http://medical-dictionary.thefreedictionary.com) 
webpages and edited accordingly. 
The clinical manifestations of the disease are often moderate if they do exist in healthy 
individuals; unfortunately in immunocompromised individuals such as human immunodeficiency 
virus (HIV) patients the symptoms can be severe (Weiss & Dubey 2009). The diagnosis of the 
disease includes a magnetic resonance image (MRI) or a computerized tomography (CT) scan of 
the brain. Unfortunately the results from a CT scan or MRI may be inconclusive hence the 
diagnosis is coupled with microscopy, parasite cultivation or molecular methods (Miller et al. 
1998).  
1.2  ANTI-PROTOZOAN TREATMENT 
The treatment of protozoa infections is largely dependent on chemotherapy. In Leishmaniasis 
cases antimonial compounds are the first line of treatment in developing countries mainly 
because they are readily available and have a low cost however they are quite toxic (Sundar & 
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Chakravarty 2013). In developed countries amphotericin B is preferred due to its reduced 
toxicity although the treatment is expensive and many patients cannot afford it (Sundar & 
Chakravarty 2013). This is also the case in treating Chaga’s disease. The drugs of choice are 
usually benznidazole and nifurtimox which have shown great efficacy (Antunes et al. 2002). 
Nevertheless the treatment requires extended courses resulting in drug toxicity and resistance in 
some cases (Apt 2010).  
African trypanomiasis is treated according to its stages. The disease progresses in two stages 
namely the hemolymphatic stage and the CNS stage (Brun et al. 2010).  During the 
hemolymphatic stage the patients suffer from headaches, malaise, weakness and fever, while in 
the CNS stage trypomastigotes invade the CNS and the patients’ experience a disruption in their 
sleep-wake cycle resulting in a strong urge to sleep (Kennedy 2004). This is usually coupled with 
motor and sensory disorders. In the hemolymphatic stages pentamidine and suramin are the 
drugs of choice while Eflornithine is preferred in treating the CNS stage (Barrett et al. 2011). 
These drugs have adverse side effects while having limited efficacy (Delespaux & de Koning 
2007). 
The same challenges are faced in treating Toxoplasmosis. There are currently limited treatment 
options for Toxoplasmosis.  The acute forms of the disease are treated using a combination of 
sulfonamide and pyrimethamine, azithromycin is also another alternative (Pereira-Chioccola et 
al. 2009). Unfortunately adverse side effects of the pyrimethamine combination have been 
reported and the alternative azithromycin has raised some concerns about its efficacy (Weiss & 
Dubey 2009).  
In Malaria cases the treatment has relied on chloroquine but due to the extensive misuse of this 
drug there have been cases of drug resistance reported in endemic regions (Wegscheid-Gerlach 
et al. 2010). Since 2012 Artemisinin-based combination therapies (ACTs) are the best on the 
market however the therapy is inaccessible in developing countries. Since ACTs are a 
combination therapy there is misuse of the drug due to the lack of knowledge thus drug 
resistance is emerging (World Health Organization 2013).   
The decreased efficacy, toxicity and inaccessibility associated with anti-protozoan treatments 
have spurred on the research for new drugs and drug targets. Research groups have focused on 
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cysteine proteases in an effort to identify novel drug targets due to their role in parasite host cell 
invasion and rupture (McKerrow et al. 2006).  
1.3 CYSTEINE PROTEASES 
Proteases are a group of enzymes that facilitate the splitting of proteins into smaller fragments 
and can be grouped into various classes such as cysteine, serine, aspartate, threonine and 
metalloproteases, according to their catalytic activity and substrate specificity (Grzonka et al. 
2001). Protozoan cysteine proteases are vital for host-cell invasion, host protein hydrolysis and 
the intracellular maturation of the parasite; hence they are a prerequisite for the survival and the 
proliferation of the parasite in its vector and host (Hogg et al. 2006).  It is these characteristics 
that arouse interest in cysteine proteases as potential targets for anti-protozoan drugs. 
Cysteine proteases exploit the catalytic cysteine residue localized in the active site where it 
mediates the peptide bond hydrolysis through a nucleophilic attack on the carbonyl carbon. The 
nucleophilic attack is carried out by the thiol-group in the catalytic dyad formed by the 
sulfhydryl group of the cysteine residue and the imidazole ring of the histidine residue 
(McKerrow et al. 2006).The fundamental step for this hydrolysis process is the formation of the 
S-acyl-enzyme moiety followed by the nucleophilic attack of the thiolate group which releases 
the C-terminal fragment of the cleaved protein and finally the reaction of the water molecule 
with the intermediate group releasing the N-terminal fragment of the cleaved product (Pandey et 
al. 2009). 
1.3.1 CYSTEINE PROTEASE NOMENCLATURE 
Cysteine proteases are grouped into various clans that have divergent sequence and structure 
similarity namely; clan CA, CB and CC. This study focuses on the CA clan that utilizes catalytic 
Cys, His and Asn residues that are in this perpetual order in the primary sequence of the protease 
(Pandey & Dixit 2012). The CA clan is further subdivided into families according to sequence 
similarity and identity namely; family C1 and C2. Family C1 (papain‑family) cysteine proteases 
are the best characterized cysteine proteases of parasite proteases. This family is further 
categorized into classes namely; cathespsin-L-like, cathepsin-B-like and cathepsin-F-like 
proteases (McKerrow et al. 2006). 
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The best characterized Plasmodium cysteine proteases are the falcipains, papain family (clan 
CA) from the cathepsin-L-like subclass enzymes namely; falcipain-1 (FP-1), falcipain-2 (FP-2), 
falcipain-2B (FP-2B) and falcipain-3 (FP-3) (Selzer et al. 1999). FP-2 is the most studied of all 
the falcipains hence it is used as a reference in this study. 
1.3.2 CYSTEINE PROTEASE STRUCTURE  
Cysteine proteases are initially synthesized as zymogens to prevent the potentially premature 
degradation of the protein.  The zymogen displays two major domains, the prodomain and the 
mature domain (Rosenthal et al. 2002). The prodomain is further differentiated into smaller 
domains.  At the first 35 amino acids of the prodomain N-terminus is the cytosolic prodomain, 
followed by the transmembrane made up of 20 amino acid residues  which is required for entry 
into the ER and finally the lumenal domain consisting of 188 amino acid residues. The inhibitory 
domain is located in the C-terminal portion of the prodomain (Rizzi et al. 2011). These domains 
were elucidated using transfection studies whereby the different chimeras with parts of the N-
terminal portion of the prodomain where fused to green fluorescent protein and their localization 
determined (Wang et al. 2006). 
The prodomain spans over the active site thus demonstrating a substrate inhibitory effect. To 
prevent hydrolysis the prodomain is bound to the active site in the opposite direction to that of 
substrate binding (Pandey et al. 2009). The prodomain consists of 2 α-helices located at the N-
terminal. The prodomain is anchored to the active site of the protease by a short α-helix 
following the two α-helices. The C-terminal end of the prodomain covers both the left and right 
lobes of the mature domain (Sijwali et al. 2006). Apart from inhibiting the active site of the 
inactive zymogen, the prodomain plays a key role in intracellular trafficking. Once the 
prodomain is cleaved off the cysteine proteases are activated (Wang et al. 2006).  
The mature domain consists of two lobes; the right lobe is made up of α-helices while the left 
lobe is made up of beta sheets and surface α-helices. The catalytic triad (Cysteine, Histidine and 
Asparagine) is located in the intersection between the two lobes (Wang et al. 2006). The mature 
domain houses the active site which is subdivided into 4 regions namely, sub-sites 1, 1’, 2 and 3 
( S1, S1’, S2 and S3). Of all the binding pockets S1 is the least defined, it holds the glutamine 
residue that forms the oxyanion hole that stabilizes the substrate while interacting with the 
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substrate solvent. S1’ is known to hold the highly conserved tryptophan which forms the 
hydrophobic interactions with the substrate (Sabnis et al. 2003). The S2 is the most conserved of 
the sub-sites indicating its importance in the catalytic activity of the protease. This region is 
primarily hydrophobic and it is the region that governs ligand specificity (McKerrow et al. 
2006). S3 is responsible for the stabilization of the intermediates during catalysis and interacts 
with the substrate although it is not involved in substrate specificity (Sabnis et al. 2003) (Figure 
1.6).  
 
Figure 1.6 The sub-sites are mapped onto the Plasmodium structure (2OUL) sub-site 1 is shown in red, sub-site 1’ 
in wheat, sub-site 2 in magenta and sub-site 3 in blue. The active site is shown as yellow spheres (see Chapter 
2.3.2.1). 
1.3.3 FUNCTION OF CYSTEINE PROTEASES IN PROTOZOAN 
PARASITES 
In T.gondii cysteine proteases play a vital role in parasite invasion and growth. The protease is 
present in the vacuolar compartment of the parasite, although its functions in the vacuolar 
compartment are not known it is believed that the protease is involved in protein degradation to 
facilitate the parasite maturation and food acquisition within the host (Dou & Carruthers 2011). 
In Plasmodium species protein inhibitor studies showed the role cysteine proteases play in 
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hemoglobin hydrolysis whereby the free amino acids are used for the sustenance of parasite 
osmotic stability preventing the premature bursting of the parasite and also provide space for the 
maturing intraerythrocytic parasite (Rosenthal et al. 2002). Cysteine proteases in Plasmodium 
species have also been implicated in erythrocytic invasion by merozoites and their role in this 
process was demonstrated using FP-1 inhibitors that blocked the invasion of the erythrocytic host 
in vitro by Plasmodium parasites (Wegscheid-Gerlach et al. 2010). Falcipains have also been 
implicated in the subsequent host erythrocytic rupture to release merozoites that rapidly invade 
neighbouring erythrocytes to reinitiate the asexual cycle (Blackman 2004). The cysteine protease 
role in erythrocytic rupture was illustrated by cysteine protease inhibitors leupeptin and E-64, 
which showed the aggregation of mature schizonts in cultures treated with the inhibitors (Sijwali 
et al. 2006). 
Inhibitor studies have also shown that cysteine proteases are vital in the virulence of Leishmania 
species. The study was conducted by inhibiting the cathepsin-L of Leishmania spp. and the study 
showed an 80 % decrease in parasite virulence although the parasite continued to grow (Selzer et 
al. 1999). Meirelle and co-workers in 1992 reported a similar observation in Trypanosoma 
species, when they used irreversible inhibitors for cathepsin-L and discovered that the parasite 
had reduced ability to occupy cardiomycetes thus reducing its virulence as the newly released 
amastigotes failed to move away to less inflamed regions to propagate the infection (Abdulla et 
al. 2008).  
1.3.4  CYSTEINE PROTEASES AS DRUG TARGETS 
Cysteine proteases play a critical role in the protozoan infection and lifecycle completion making 
them lucrative drug targets. Studies have been conducted whereby the models where treated with 
cysteine protease inhibitors and these studies have validated the idea of cysteine proteases as 
drug targets (McKerrow et al. 2006). Unfortunately these inhibitors lack specificity resulting in 
toxicity and inhibition of the host cysteine proteases. This is a result of the enzyme being 
ubiquitous in virtually all organisms thus making it difficult to design specific protease inhibitors 
(Selzer et al. 1999). Due to this challenge of broad specificity of chemotherapeutic agents among 
other reasons discussed in section 1.2 there is a growing need for the design of highly selective 
inhibitors that exhibit minimal toxic effects posed on the host. 
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1.4  PROBLEM STATEMENT 
Protozoan infections account for over a million deaths per year worldwide mainly young 
children and pregnant women in the sub-Saharan region in Africa (Barratt et al. 2010). A variety 
of drugs are presently accessible to treat these infections; however, treatment is currently limited 
by drug resistance, toxicity, and high cost (Bousema & Drakeley 2011). Therefore, there is a 
need for the development of effective treatment against these infections. Cysteine proteases play 
a vital role in the infectivity of the protozoan parasite in the human host hence they have been 
validated as a viable drug target (Sijwali et al. 2006).  Cysteine proteases in general have broad 
substrate specificity which poses a huge challenge in chemotherapy design as the substrate 
inhibitors display poor selectivity towards the human cysteine proteases and parasite cysteine 
proteases; which is the main source of drug toxicity (Ettari et al. 2010). It is for this reason that 
there is a need for the design of protozoan cysteine protease inhibitors that are specific to the 
parasite.  
This study focuses on the differences and similarities between the protozoan cysteine proteases 
as well as their host and vector cysteine proteases as a step towards designing specific and 
selective treatment against protozoan infections.  
1.4.1 HYPOTHESIS 
There are distinct differences between protozoan cysteine proteases and their respective host and 
vector cysteine proteases primary structure which could be vital in drug design. 
1.4.2 AIM AND OBJECTIVES 
In previous studies conducted by McKerrow and co-workers, the size and isoelectric points of 
both the catalytic domain and prodomain of the protozoan and human cysteine proteases were 
elucidated and compared however the study did not include other properties that influence the 
activity of the cysteine proteases. Hence to date there is limited knowledge on the differences 
attributed by the respective protein sequences, between the catalytic domains of the cysteine 
proteases of protozoa and their respective hosts and vectors. This has resulted in the failure to 
identify specific inhibitors for the cysteine proteases of protozoan parasites hence the rising 
mortalities due to the diseases the parasites cause. This study aims to fill this knowledge gap 
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through establishing the catalytic domain similarities and differences between the protozoans, 
their host and vector cysteine proteases with regard to their physicochemical properties 
(molecular weight, aromaticity, isoelectric point, GRAVY and instability index), motifs and 
evolutionary relationships; through a sequence analysis of the cysteine proteases of the protozoa, 
host and vector is performed followed by a phylogenetic analysis, motif analysis, 
physicochemical analysis and finally a statistical analysis to validate the physicochemical 
analysis. The results obtained from this study will prove vital in expanding the available 
knowledge regarding specific inhibitor design of anti-protozoans. 
1.4.3  SPECIFIC OBJECTIVES 
 Retrieve the sequences from the NCBI website and split the sequences into individual 
domains 
 Perform a multiple sequence alignment of the catalytic domain to identify the regions of 
similarity and divergence among the retrieved sequences  
 Evaluate evolutionary relatedness of the sequences through phylogenetic tree calculations 
using the optimal alignment  
 Investigate common and unique patterns through motif analysis of both the full length 
sequence and the catalytic domain 
 Establish the motifs functional or structural relevance by mapping the catalytic domain 
motifs to the available FP-2 3D structure 
 Identify the amino acids responsible for observed patterns through an amino acid 
composition analysis of the catalytic domain and the sub-site regions 
 Investigate the effect the amino acids have on the protein characteristics through 
physicochemical properties analysis of the catalytic domain and the full length sequences 
 Visualize the physicochemical data using box plots  
 Statistically validate the box plots data using the Kruskal-Wallis test 
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CHAPTER TWO 
2.  SEQUENCE AND PHYLOGENETIC 
ANALYSIS 
The centre of interest in this chapter is to identify the orthologs of FP-2 in the other six 
Plasmodium species which include P.vivax, P.knowlesi, P.ovale, P.berghei, P.yoelli and 
P.chabaudi and the homologs from other protozoan parasites namely: Leishmania, Toxoplasma 
gondii, Trypanosoma brucei and cruzi and Entamoeba histolytica; as well as their respective host 
and vector organisms. The retrieved sequences were compared using multiple sequence 
alignment (MSA) and phylogenetic tree calculations to establish the functional residues as well 
as the evolutionary relationships respectively, which could be vital in antiprotozoan drug design. 
2.1  INTRODUCTION  
Cysteine proteases are virtually ubiquitous in all organisms and their major role in living 
organisms is to degrade peptides and proteins. There are also known to be virulence factors in 
parasites hence they have been implicated in the development and progression of diseases 
especially protozoan diseases which are the epicentre of this study (Grzonka et al. 2001). Like 
most proteins, cysteine proteases can be retrieved from open source databases such as NCBI 
(http://www.ncbi.nlm.nih.gov/). The retrieved sequences can be aligned to provide a platform for 
the identification and characterization of proteins, phylogeny, sequence similarities and 
differences inferences (Edgar 2004). The proteins that exhibit similarities are referred to as 
homologs which can be classified into three groups; orthologs which are evolutionary related 
proteins but found in different species, paralogs which are a duplication of proteins found within 
the same organism and xenologs are also related proteins in different organisms which occur 
through horizontal gene transfer (Tatusov et al. 1997).  
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2.1.1 SEQUENCE ALIGNMENT APPROACHES AND 
ALGORITHMS 
Sequence alignment involves the determination of insertions and deletions and their locations 
within the sequences, which would have arisen during sequences divergence from a common 
genetic ancestor (Xiong 2006). Consequently alignment is the starting point of virtually all 
comparative study analyses of molecular data such as this one which involves the identification 
of homologous sites and phylogenetic tree construction (Rose et al. 2011). 
A number of sequences can be aligned simultaneously through multiple sequence alignment 
(MSA) which could be either global and/or local alignment. Global alignment is defined as the 
alignment across the entire length of the compared sequences that uses the Needleman-Wunsch 
algorithm (Needleman & Wunsch 1970). On the contrary local alignment aligns the similar local 
regions between the studied sequences using the Smith-Waterman algorithm. Local alignment 
method is ideal for evolutionary distant sequences that have similar domains (Smith & 
Waterman 1981). Both global and local alignments are effectively achieved through an algorithm 
known as dynamic programing which is a technique that determines optimal alignments by 
revealing similarities between genes (Xiong 2006).  
Dynamic programing achieves optimal alignments through the use of scoring matrices. There are 
mainly two types of scoring matrices namely Point Accepted Mutations (PAM) and Blocks of 
Amino Acid Substitution Matrix (BLOSUM) are the most common matrices (Henikoff & 
Henikoff 1992). In this study the BLOSUM matrices were employed.  
BLOSUM is derived from the direct observation of possible residue substitutions in multiple 
sequence alignments. This scoring matrix was constructed from over 2000 conserved amino acid 
patterns which are called blocks (un-gapped alignments less than sixty amino acids in length). 
The frequency of the amino acid substitutions within the un-gapped blocks is calculated into a 
substitution matrix. The BLOSUM matrix numbers represent the percentage identity values of 
sequences used to construct the matrix, for example BLOSUM62 shows that the sequences used 
to construct the matrix share a sequence identity of 62%. For each residue that is aligned to 
nothing a gap is introduced and is penalized which lowers the alignment score. Optimal 
alignments would have the highest score and minimal penalties (Henikoff & Henikoff 1992). 
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2.1.2 DATABASE SIMILARITY SEARCH AND SEQUENCE 
RETRIEVAL TOOLS 
Sequences are retrieved from the databases using search tools such as Basic Local Alignment 
Search Tool (BLAST) which searches for the query sequence homologs in the database. BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) uses heuristic database searching algorithms to align the 
query sequence with all sequences within the database (Ye et al. 2006). The sequences within the 
sequence similarity threshold show that the similarity did not occur by chance and the results are 
presented as a list sorted according to statistical significance and the E-value. The E-value is the 
parameter that depicts the probability that the query sequence alignment with the database 
sequence did not match by random chance hence the higher the value the less significant the 
alignment (Altschul 1998). 
BLAST has a lot of variants that include BLASTN, BLASTP, BLASTX TBLASTN, and 
TBLASTX. In this study BLASTP is used, it uses protein sequence queries to search against a 
database of protein sequences. To increase its sensitivity BLAST has a variant PSI-BLAST that 
uses profiles to find remote sequence homologs by searching against sequence databases in an 
automated manner (Xiong 2006).  
HHpred (http://toolkit.tuebingen.mpg.de/hhpred) is another speedy and sensitive search tool that 
reveals homologous proteins across a variety of protein databases by identifying remote 
homologs and predicting protein structures. The server uses Hidden Markov Models (HMM-
HMM comparison) (Söding et al. 2005) whereby the initial query sequence is used to identify 
and align identified homologs using PSI-BLAST. The profiles generated by PSI-BLAST are then 
used as input into PSIPRED to give results that include comprehensive secondary structure 
prediction (Jones 1999). This alignment is used to construct HMM profiles that provide the 
probability of an insert, deletion and match for each HMM profile column in the alignment 
(Eddy 1998). HHsearch is then employed to query the consensus HMM profile against a 
database of choice through HMM-HMM comparison (Söding et al. 2005). This search method is 
more efficient and sensitive compared to the position specific scoring matrices. HHpred output 
gives alignment statistics together with the alignment. The statistics include the percentage 
identity, E-value, similarity and the probability of the homology to the query. 
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2.1.3 MULTIPLE SEQUENCE ALIGNMENTS 
Related sequences can be identified through database similarity search as described earlier in this 
chapter. The retrieved homologs can be compared to get a clearer view of sequence conservation 
through multiple sequence alignment (MSA) which reveals more conserved motifs, sequence 
patterns and evolutionary relationships (Taylor 1998).  Heuristic approaches have been 
developed to carry out MSA, such as iterative alignment, progressive alignment and block-based 
alignment (Thompson et al. 1999). Progressive MSA is engineered in a stepwise cluster which 
speeds up the alignment. Initially the query sequence is pairwise aligned with each of the 
sequences using the Needleman–Wunsch global alignment method. The sequence similarity 
scores or identity scores depending on the substitution matrix used, from the pairwise alignment 
are recorded. The scores are then used to calculate the evolutionary distances between the 
sequences to build distance matrix. A phylogenetic tree based on the distance matrix is generated 
using the neighbour-joining method which indicates the evolutionary closeness of the sequences. 
The resulting tree is used as a guide for the realignment of the sequences. Using the guide tree, 
the two closest sequences are re-aligned and converted into a consensus sequence. The most 
similar sequence is aligned with the consensus sequence using dynamic programing. The more 
distantly related sequences are added and the resulting consensus sequence is used for the next 
round of alignment. This process is repeated until all the sequences are added (Xiong 2006).  
There are a number of currently available MSA programs whose basis is progressive alignment. 
CLUSTAL is one of such programs. Unfortunately progressive alignment uses global alignment 
in some cases and may therefore fail to identify conserved domains and motifs in distantly 
related sequences with varying lengths. For such sequences the consistency-based method is 
ideal. T-coffee is a program that uses the consistency based method which uses both the local 
and global pairwise alignments. T-coffee does not generate its own sequences; it uses CLUSTAL 
for local alignments and LALIGN for global alignments (Pei & Grishin 2007). The program 
assesses the alignments and then weights them on the basis of sequence identity. Once this has 
been done the program proceeds to extend the library of local and global alignments (Nuin et al. 
2006). The program then constructs a guide tree based on the position specific scoring matrix 
built from the library. From this point the program uses progressive alignment to generate an 
MSA (Di Tommaso et al. 2011). 
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Another example of a consistency based MSA alignment program is Profile multiple alignment 
with local structure (PROMALS3D) which provides both sequence and structural alignment (Pei 
et al. 2008). The program starts off by clustering the sequences followed by performing a 
pairwise alignment of similar sequences using the scoring matrix BLOSUM62. From each 
cluster a representative sequence is selected which is referred to as the ‘target sequence’. The 
target sequences are used as input into PSI-BLAST to search for additional homologs from the 
database Uniprot non-redundant reference databases facts (UNIREF90) and secondary structure 
prediction from Protein structure prediction server (PSIPRED) (Altschul 1998). A consistency 
scoring function is generated from the residue profiles obtained from PSI-BLAST and PSIPRED; 
the scoring function is used to progressively align the representative target sequences. The 
complete MSA is obtained by adding the pre-aligned clusters to the representative sequence 
alignment (Pei & Grishin 2007). 
Consistency based approaches can be sped up by using the fast Fourier transform approximation; 
one such program is MAFFT which uses progressive alignment to construct a preliminary 
alignment (Katoh et al. 2002). MAFFT initially calculates the distance between every pair of 
input sequences and the distances are used to construct a guide tree using the unweighted pair 
group method with arithmetic mean (UPGMA) approach. The input sequences are then 
progressively aligned according to the guide tree branching order. The initial distance matrix is 
less accurate hence a new guide tree is constructed based on the new distance matrix generated 
from the initial guide tree. Progressive alignment is re-done using the new guide tree. The new 
alignment is enhanced by the iterative refinement method whereby the progressive alignment 
process is iterated until the scoring alignment obtained is worse than the previous one (Katoh et 
al. 2002). 
2.1.4 PHYLOGENETIC ANALYSIS 
Multiple sequence alignments provide a platform for revealing sequence identities and 
similarities as well as reveal conservation among aligned residues; however they are not 
equipped to provide accurate phylogenetic inferences and protein groupings deductions (Kosiol 
et al. 2008). To achieve these, phylogenetic trees are used. Phylogenetic trees show the 
evolutionary relationships among protein sequences however the resulting tree depends on the 
algorithm and evolutionary assumptions used (Xiong 2006).  
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Phylogenetic analysis allows protein sequence history to be evaluated. The branching order of 
the trees illustrates the sequence evolutionary divergence. Phylogenetic tree construction requires 
a multiple sequence alignment input therefore it is mandatory that the MSA be accurate. The 
MSA is used to construct the phylogenetic models which are used as evolutionary distance 
approximates (Xiong 2006).  
There are currently a variety of programs that are available for phylogenetic tree calculations. 
One such program is MEGA5, it takes DNA and protein sequences as input and has an inbuilt 
alignment tool, the program can also accept already aligned sequences. MEGA5 evaluates the 
evolutionary distances between the sequences and then generates a phylogenetic tree based on 
the estimated distances.  The evolutionary distances are essential in gauging the sequence 
divergence and MEGA5 uses statistical models to do this. The models produce distance 
estimations and convert them to a distance matrix which is then used to construct a phylogenetic 
tree (Tamura et al. 2011). 
The phylogenetic trees can be calculated either by distanced based methods such as the 
neighbour joining method or character based methods such as maximum likelihood. In this study 
the maximum likelihood method is used. Maximum likelihood is a character based approach that 
selects the best tree based on the probabilistic models. The tree with the highest probability of 
reproducing the observed data is selected as the optimal tree. This method conducts its analysis 
on the entire alignment unlike the informative sites only (Kosiol et al. 2008). The input is a set of 
observed sequences as well as a substitution model. The program then calculates the probability 
of a residue to evolve to a different residue after time, the probability values are determined by 
the substitution model, these are termed likelihood scores. The likelihood for the topology is the 
sum of likelihood scores for each branch in the tree. The tree with the highest likelihood scores is 
considered the optimal tree (Xiong 2006).  
The output trees need to be validated for reliability to infer phylogeny using resampling 
strategies such as bootstrapping and jackknifing. The bootstrap method repeatedly alters the 
input data and creates tree according to the replicates required (Xiong 2006). The generated trees 
are compared to the original tree to test for robustness and they are visualized using the MEGA5 
tree explorer to clearly show the evolutionary diversity or similarity within a family of species 
that are being studied (Tamura et al. 2011). 
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2.2 METHODOLOGY  
Sixty-two sequences of clan CA cysteine proteases from protozoan parasites, their hosts and 
vectors were retrieved, aligned and their phylogenetic divergences or similarities analysed. The 
FP-2 Plasmodium sequence was used as the query sequence. The tools and procedures employed 
are described below.  
2.2.1 DATA RETRIEVAL 
The Falcipain-2A (FP-2A) sequence was retrieved from the NCBI databases. Using FP-2A as a 
query sequence orthologs from the Leishmania, Toxoplasma, Trypanosoma and Entamoeba 
species as well as their respective host and vector sequences were retrieved from the NCBI 
database. The sequences of the homolog structures were identified using HHpred. The FP-2 
sequence was used as the template in HHpred to identify the homolog structures and the default 
parameters were used. The homolog structures with complete structures, a low E-value and 100 
% probability, which were sourced from protozoan parasites that are being studied in this project, 
their respective hosts and vectors were selected and then the sequences were retrieved from the 
NCBI database A total of 62 FP-2 orthologs were retrieved from the NCBI BLASTP tool 
through BLAST with default alignment parameters of BLOSUM-62 scoring matrix, a gap 
existence and extension cost of 11 and 1 respectively and a word-size of 3. The BLAST method 
occurred in two stages. In the first stage FP-2 was used as the query and it returned the orthologs 
in other organisms. In the second stage (reverse BLAST) the ortholog sequence was used as the 
query and ideally it should return FP-2 as the first ortholog hit, however this was not the case in 
all the orthologs, some returned FP-3 as the first hit. This was probably due to the fact that the 
orthologs were more closely related to FP-3 than FP-2 to confirm this sequence identities are 
indicated below (Appendix A-III).   
The sequence analysis included 20 parasite species, 16 and 26 host and vector sequences 
respectively. Only the clan CA proteases were retrieved in this study. 
2.2.2 MULTIPLE SEQUENCE ALIGNMENT  
The 62 retrieved sequences were then aligned to identify the regions of similarity and divergence 
among the species and therefore infer homology and evolutionary relationships (Edgar 2004). 
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The alignment programs MAFFT (Katoh et al. 2002), TCOFFEE (Di Tommaso et al. 2011), 
EXPRESSO (Armougom et al. 2006) and PROMALS3D (Pei et al. 2008), were used to perform 
MSA. The homolog structures from FP-2 (2OUL), FP-3 (3BWK), T.gondii (3F75), H.sapiens-L 
and K (2XU3 and 1BY8 respectively), S.scrofa-H (8PCH) and M.musculus (4BS6) were used as 
the templates in the PROMALS3D alignment. These programs were accessed from the web 
server and their default parameters were used. A fasta file containing all the retrieved sequences 
was uploaded into each of the above mentioned programs and the MSA was run automatically. 
Since the region of interest in this study was the mature domain only the mature domain was 
aligned. The alignments were viewed on Jalview alignment viewer and the MAFFT alignment 
was observed as the best quality alignment. 
      2.2.3    PHYLOGENETIC TREE CALCULATIONS  
The MAFFT alignment which had the most accurate alignment was used as the dataset for tree 
generation. The calculations were performed on MEGAv5 to generate maximum likelihood 
phylogenetic trees, which showed the evolutionary relatedness of the cysteine proteases across 
all the studied organisms. The maximum likelihood approach calculates the probability that the 
input data in this case the MAFFT alignment will be observed under a particular phylogenetic 
tree and the selected substitution model. The substitution models provided a set of parameters 
that describe the evolutionary process. In this study five substitution models were used, 
WAG+G, WAG+G+I, rtREV+G+I, JTT+G and JTT+G+I since these models had the top BIC 
(Bayesian Information Criterion) scores.  The other parameters included in this study were the 
site coverage threshold which was set at complete deletion and a bootstrap value of 1000 for the 
purpose of identifying the confidence levels of the inner nodes of the topology. The other 
parameters not discussed were set at default. 
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2.3  RESULTS AND DISCUSSION  
In this section the data retrieval, multiple sequence alignment and phylogenetic tree calculation 
results are reported. The residue numbering is in reference to FP-2. The sequences are referred to 
by their common names (Appendix A-I). 
          2.3.1   DATA RETRIEVAL 
FP-2 orthologs were retrieved by reverse BLAST from the NCBI database and the sequences of 
the homolog structures were identified (Appendix A-I). 
All the retrieved sequences were from the cathepsin L-like sub-class and they had low E-values 
and sequences identities were greater than 30% suggesting that the retrieved sequences were 
significant hits. The sequences had two functional domains namely; the prodomain which is a 
propeptide that inhibits the activity of the cysteine protease and the catalytic domain. For the 
purpose of this study only the catalytic domain was analysed. The regions marking the 
prodomain and the catalytic domain are illustrated in the appendix (A-II). In addition to the 
identification of the functional domains’ regions the first and second hits returned by the NCBI 
database were attained as well as their respective sequence identities as illustrated in the 
appendix (A-III). 
In some indicated sequences FP-3 was the first hit showing that the sequences were more closely 
related to FP-3 than FP-2. Further studies of the sequences relatedness were determined by 
phylogenetic tree calculations. 
        2.3.2  MULTIPLE SEQUENCE ALIGNMENT  
The retrieved sequences were aligned using MAFFT, PROMALS3D, TCOFFEE and 
EXPRESSO alignment algorithms. The alignments from all the programs are shown in the 
appendix (A-IV-VII). The alignment generated by the MAFFT algorithm was chosen as the best 
alignment because it aligned the conserved regions such as catalytic and sub-site residues as well 
as the insert regions well relative to the other alignment programs that were used and had 
minimal gaps.  The prodomain and the catalytic domain regions were separated and the results 
reported are for the mature domain.  
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In analysing the mature domain the catalytic residues were identified. The full alignment can be 
found in the appendix section (A-IV). The best alignment is shown below (Figure 2.1) but only 
the regions that are known to be conserved are shown to justify the choice of best alignment.  
4
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 Figure 2.1 MAFFT alignment of the cysteine proteases’ catalytic domain as viewed on Jalview. The purple residues indicate the 
Plasmodium species insert that forms part of the nose-like protrusion, the royal blue residues indicate the catalytic residues while the 
orange residues indicate the cysteine residues involved in disulphide bridge formation. The green residues illustrate the sub-site 1 
residues, the brown residues show the sub-site 2 residues, the light blue residues indicate the sub-site1’ residues and the red residues 
show the sub-site 3 residues. 
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The Plasmodium species have an N-terminal insert which forms the arm-like protrusion which is 
believed to be involved in the folding of the prodomain. The Plasmodium species also have a C-
terminal insert which forms the nose-like protrusion and is thought to be the haemoglobin 
binding motif. The sequences also showed conservation of six cysteine residues that form 
disulphide bridges. The Plasmodium sequences have an extra pair of cysteine residues that 
stabilize the structure of the mature domain during its active conformation by forming a loop in 
the S2 and S1’ sub-sites in FP-2. 
       2.3.2.1    SUB-SITES ANALYSIS  
Residues from each of the sub-sites namely; 1, 2, 3 and 1’ were analysed (Figure 2.2). 
 
Figure 2.2 Sub-sites map onto the FP-2 structure (2OUL). The catalytic residues are shown in yellow while sub-
sites 1, 1’, 2 and 3 are shown in wheat, green, magenta and blue respectively. The rest of the protein is slate blue. 
The conserved cysteine residues are shown in red.  
The sub-site regions shown in Figure 2.2 were chosen by selecting the residues known to 
constitute these regions as indicated in Appendix A-VIII.  
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From the analysis as indicated in the appendix (A-VIII), the sub-site 1 and 1’ residues are 
conserved while those in sub-site 2 and 3 are variable. The sub-site 1 residues are conserved 
although the hydrophilic serine residues in all the other sequences are substituted by the 
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hydrophobic residue alanine in the cathepsin-S proteases and glutamine in cathepsin-O proteases. 
In the cathepsin-W proteases the serine residue is substituted by the cysteine residue also known 
as the ‘orphan’ residue which is a signature of the cathepsin-Ws (Brinkworth et al. 2000). Also 
within the sub-site the hydrophobic residues tend to alternate between methionine in cathepsin-
W proteases and phenylalanine in the rest of the proteases. The glutamine residue is thoroughly 
conserved due to its catalytic role of stabilizing the oxyanion hole during catalysis.  
Although sub-site 2 is highly substituted, the tryptophan and glycine residues are conserved 
across all species since they are residues responsible for forming hydrophobic interactions with 
the substrate as well hydrogen bonding respectively. In sub-site 3 alanine and phenylalanine are 
well conserved across all organisms with the exception of cathepsin-O and cathepsin-F proteases 
where phenylalanine is substituted by leucine and tyrosine respectively. Valine and tryptophan 
are well conserved in sub-site 1’ to maintain the hydrophobic interactions with substrates. The 
hydrophilic asparagine residues are substituted by the electrically charged aspartic acid residues 
in cathepsin-L proteases.  
The residue positions of the sub-sites were residue numbers 279, 282, 284, 288 and 279; 395, 
416, 418, 419, 448 and 449; 286, 321, 325, 327, 328, 329 and 395 and 415 477 478 479 for sub-
sites 1, 1’, 2 and 3 respectively. 
       2.3.3    PHYLOGENETIC ANALYSIS 
As previously discussed in the methodology section the cysteine proteases were selected from 
protozoan species as well as their respective host and vector organisms. Cysteine proteases are 
virtually ubiquitous and are known to have a conserved mechanism of action therefore 
substantial differences can be exploited for inhibitor selectivity. To assess the evolutionary 
relatedness between the proteases a phylogenetic analysis was employed (Figure 2.3).  
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Figure 2.3 Phylogenetic tree of FP-2 and its orthologs based on the alignment generated by the MAFFT algorithm. 
The maximum likelihood tree was generated using MEGA5. The values indicate the bootstrap statistical analysis 
values at each inner node which specify percentage probability of its occurrence. The tree is based on the WAG+G 
statistical model. The red branch colours indicate the host and the vector species.  
The phylogenetic tree showed that the host and vector species did not cluster according to the 
organisms they came from but rather the type of cathepsins they were, the K-cathepsins clustered 
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together and the same was observed for S, L, H, W, F and O-cathepsins. Interestingly the 
T.brucei and T.cruzi species clustered with the Leishmania proteases showing close relatedness 
between these species. As expected the Plasmodium species clustered together although FP-1 
diverged from the rest of the Plasmodium species showing that it is distantly related from the 
other Plasmodium species. This is also evident from the multiple sequence alignment as FP-1 has 
a longer insert relative to other Plasmodium species. The murine malarial Plasmodium species 
clustered together, separate from the rest of the Plasmodium species, this is interesting because 
the murine species are known infect primates in Central Africa unlike the other Plasmodium 
species which infect humans.  Although KP-2 is known to be a human malarial protease it was 
observed to be closer related to the murine species instead of the human malarial species.  FP-2A 
and -2B branched out together and were observed to be closely related to FP-3 and VP-2. 
The clustering patterns observed in Figure 2.3 may have resulted from specific motifs within 
related proteases that may lead to them possessing similar physicochemical proteins. In this 
study these distinct features were further investigated through motif analysis and 
physicochemical properties analysis as discussed in Chapter 3. 
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CHAPTER THREE 
3. PHYSICOCHEMICAL PROPERTIES AND 
MOTIF ANALYSIS 
This study aims to conduct a comparative analysis of parasitic protozoan cysteine proteases as 
well as their respective hosts and vectors with special interest in Plasmodium cysteine proteases. 
This chapter will therefore focus on the physicochemical properties and motif analysis of FP-2; a 
papain family cysteine protease from P.falciparum, its orthologs from other protozoan parasites 
and their respective host and vector homologs. The physicochemical analysis is achieved via 
BioPython scripting and statistically analysed using box plots and the Kruskal-Wallis test. The 
motif analysis is performed using MEME. This is done to discover motifs and amino acid 
residues that are distinct in protozoan parasites and potentially vital in the protein function. 
Cysteine proteases are virtually ubiquitous in all living organisms therefore a comparative study 
is imperative in order to unearth distinct differences among the protozoan, host and vector 
cysteine proteases as a step towards designing selective and specific cysteine protease inhibitors. 
3.1 INTRODUCTION  
Protein polypeptide chains tend to fold into secondary structural elements. Within the structural 
elements there are observed patterns of amino acid residues whose abstraction forms a protein 
motif (Bailey et al. 2006). Protein motifs can be organized into four classes, sequence motifs, 
sequence-structure motifs, and structure motifs and structure-sequence motifs (Bork & Koonin 
1996). 
Sequence motifs are amino acid sequence patterns whose topological order can be indirectly 
inferred. Whereas sequence-structure motifs are primary structure patterns with a secondary 
structure identifier attached to at least one of the residues.  From these motifs the structure of a 
protein can be interpreted. On the contrary structure motifs are not associated with the sequence 
motifs, they are the common parts observed in different topologies in known structures. The 
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structural motifs are used in identifying and classifying proteins. Structure-sequence motifs 
combine the primary and tertiary structure information. There is no need for a direct implication 
between the sequences. These motifs can be described in either of two ways, sequence logos or 
position weight matrices (PWM) (Bailey et al. 2006). 
There are available motif discovery algorithms that output their results in each of the two 
methods. Some motif discovery algorithms display a list of occurrences of the motifs within the 
sequence instead of the descriptive output. The set of occurrences can be changed to PWMs or 
regular expressions (Bailey 2008).  
Regular expressions describe the pattern of amino acid residues that match the motif. Whereas 
the position weight matrices define the probability of each residue letter occurring at that 
particular position (van Helden et al. 1998). Both of these are used by motif discovery algorithms 
due to their advantages. The regular expressions have an advantage of easy visualization and the 
statistical significance evaluation can be easily defined on regular expressions. Whereas PWMs 
have the advantage of a more elaborate description of a motif as it provides the specific position 
of the motif rather than just the fact that there is a match or not. However unlike regular 
expressions PWMs are difficult for algorithms to compute since they are computationally 
expensive (Staden 1989). MEME is an example of a PWM based algorithm. It works by looking 
for repeated, ungapped sequence patterns within the input sequences (Bailey et al. 2006).  
3.1.2 MEME: MOTIF DISCOVERY ALGORITHM 
In functionally related proteins, there are common structural characteristics that exist. Within the 
protein sequences the motifs can represent enzyme active sites among other things (Bork & 
Koonin 1996). The conserved functional parts can be used to predict the function of unknown 
proteins and they are known as motifs which can be identified and characterized using various 
algorithms. However the structures are not always available so to cater for this the local 
conserved segments can be identified from the primary sequences (Hu et al. 2005). In this study 
the motifs were discovered from the amino acid sequences and identified using MEME.  
MEME (Multiple Expectation Maximization Estimation) allows the discovery of motifs in 
protein sequences and the algorithm is based expectation maximization (EM) technique. The 
user inputs a set of sequences in fasta format that are believed to possess common motifs. By 
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default MEME finds up to three motifs, which may be found in some or all of the input 
sequences. The default motif widths are between 6 and 50 although these default settings maybe 
changed by the user (Bailey et al. 2006). The width and number of occurrences for each motif is 
set up in such a way that the probability of finding an equally well conserved motif within 
random sequences is minimized (E-value) (Bailey 2008).  
For each motif with a width w, MEME breaks down the input sequences into w-mers. MEME 
then uses the model and background components to conclude whether the w-mer is a motif or a 
background sequence. An increase in number of sequences and sequence length results in an 
increase in the search space. MEME has an HTML, XML and TXT output (Bailey et al. 2006). 
The MEME HTML output shows the discovered motifs as blocks on their relative positions in 
each of the input sequences. The motifs appear as local multiple alignments of the input 
sequences.  HTML output is generated from the XML output. XML is designed for machine 
reading as it lacks the visualizations found in the HTML output. The original MEME output is 
the plain text document output and like the HTML output it is also self-explanatory (Bailey et al. 
2006).  
Like most motif discovery algorithms MEME follows four basic steps for motif discovery.  In 
the first step the input sequences believed to possess similar motifs are assembled, this is 
followed by the second step in which the low-complexity regions and known repeating elements 
in the sequences are masked.  This third step involves running the algorithm using the parameters 
set by the user. In the fourth step the discovered motifs are evaluated, and the motifs that are 
chance artifacts and do not represent any structurally or functional relevance are removed. 
During this step the discovered motifs are evaluated on whether they represent a known motif or 
if they are conserved in orthologous sequences. If they are neither then they are weeded out 
(Bailey 2008).  
3.1.3  PROTEIN PHYSICOCHEMICAL PROPERTIES 
Sequence and motif analysis does not take into account the protein physicochemical properties. 
The physicochemical properties have an effect on the protein function as well as its structure, 
and their analysis elucidates patterns among the group of proteins being analyzed that may not be 
obvious in sequence, phylogenetic and motif analysis (Cozzone 2002). In this study six 
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physicochemical properties are evaluated namely; amino acid composition, aromaticity, 
GRAVY, instability index, iso-electric point (pI) and molecular weight.  
The protein aromaticity influences the stability of the protein through the interactions between 
the aromatic residues, histidine, tyrosine, tryptophan and phenylalanine (Tartaglia et al. 2004).  
These residues contain an aromatic ring in which π-electrons are free to cycle around the ring 
such that aromatic residues with 4.5Å and 7Å apart from each other can form aromatic 
interactions through the interaction of the circulating electrons (Lanzarotti et al. 2011). 
Aromaticity is calculated by dividing the total number of aromatic residues with the total number 
of residues within the sequence (Cozzone 2002).  
Aromaticity is not the only property that can be used to determine protein stability; the Grand 
Average of Hydropathy (GRAVY) can be used to determine the hydrophilic and hydrophobic 
properties that also influence the protein stability. In GRAVY calculation the hydrophobic and 
hydrophilic properties of the residues’ side chains are taken into account. The GRAVY index is 
calculated by adding the hydropathy values of the amino acid residues in the protein sequence 
and then dividing by the total number of residues within the sequence. The positive values show 
polar proteins while the negative values indicate the non-polar proteins therefore the lower the 
GRAVY value the more hydrophilic the protein is (Kyte & Doolittle 1982). 
Protein stability determines how fast the protein will degrade when exposed to extreme 
temperatures and pH as well as natural proteolysis, this is called the half-life. The instability 
index defines the half-life of a protein in a test tube. An instability index above 40 indicates that 
the protein is unstable whereas a value less than 40 indicates protein stability (Idicula-Thomas & 
Balaji 2005). The pI can be used to further describe protein solubility. The pI is the pH value 
where the protein does not carry a net charge. The pI can also be used to define the pH at which 
the protein is at its minimal solubilty and can therefore be purified in wet laboratory assays such 
as ion exchange chromatography for further characterization and interaction with potential 
ligands (Lecaille et al. 2002). 
In this study the observed physicochemical properties will be validated using hypothesis testing 
specifically the Kruskal-Wallis test to test whether the data has the same distribution. 
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3.1.4  STATISTICAL ANALYSIS: KRUSKAL-WALLIS TEST 
The purpose of the Kruskal-Wallis test is to determine whether there is a significant difference 
between the three or more samples at an alpha level of 0.05 (Kruskal & Wallis 1952). The test 
basically answers the questions: is there a difference in the samples or the variation that is 
observed merely occurs by chance and represents the expected differences within a randomly 
sampled population; these are termed the hypotheses (Delaney & Vargha 2002). The null 
hypothesis (H0) states that there are no differences among the samples while the alternative 
hypothesis (H1) postulates that there are significant differences among the samples (Chan & 
Walmsley 1997). To reach the conclusion the final value of the H statistic called the p-value is 
used. A p-value less than the alpha level 0.05 indicates that the null hypothesis can be rejected 
and the samples have a significant difference while a p-value greater than the alpha level 
indicates a lack of sufficient evidence to reject the null hypothesis meaning that the variation 
observed among the samples occurred by chance therefore they are not different (Kruskal & 
Wallis 1952).   
The Kruskal-Wallis has assumptions regarding its use, firstly it assumes that the samples are 
independent of each other, secondly the sample scores in one sample group are independent of 
the scores in the other groups, thirdly the sample scores within the same group are independent 
of each other and finally the variable under study has a continuous distribution (Chan & 
Walmsley 1997). Since the sample data in this study satisfied the assumptions the Kruskal-
Wallis test was appropriate to use. 
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3.2  METHODOLOGY 
A motif analysis of the protein sequences from FP-2 and its orthologs from the six Plasmodium 
species as well its homologs from the E.histolytica, T.brucei, T.cruzi, L.major, L.aethiopica, 
L.mexicana, L.tropica, T.gondii; their respective hosts and vectors was performed. The 
sequences were grouped in 3 groups namely; hosts, vectors and parasites and their 
physicochemical properties calculated. These analyses were performed on both the catalytic 
domain sequences and the full length sequences. The procedures and tools used are described in 
this section. 
3.2.1 MOTIF ANALYSIS 
To analyze the conserved motifs the MEME motif search 
(http://meme.sdsc.edu/meme/website/meme.html) was used on a set of 62 sequences of both the 
catalytic domain sequences and the full length sequences. The criterion for selecting the data set 
is described in the data retrieval section (section 2.2.1). MEME was set to identify up to 100 
motifs of 6 and 50 amino acids with zero or one occurrence per sequence, at p-value of <0.0001. 
The observed motifs were visualized using a heat map which is a 2D graphical representation of 
motifs represented as colours; generated through Python scripting. The script determined in how 
many sequences the motifs identified by MEME occurred and then converted it into a 
percentage. It then used the MAST output to identify the statistically significant motifs using the 
p-value. The motifs with low p-values were considered significant and were used as input into 
the heat map while the motifs with high p-values were removed. The significant motifs were then 
plotted on heat map together with the input sequences whereby the most frequent motifs were 
shown in red while the least frequent were shown in blue. 
3.2.2 PHYSICOCHEMICAL ANALYSIS  
The physicochemical properties of the retrieved protein sequences were investigated using 
BioPython scripting. The properties that were investigated include GRAVY, instability index, 
aromaticity, isoelectric point, molecular weight and amino acid composition. The 
physicochemical properties investigation results were visualized using box plots calculated on R 
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and 3D bar plots in the case of amino acid composition analysis. Both the catalytic domain 
sequences and full length sequences were evaluated.  
3.3 RESULTS AND DISCUSSION 
The results obtained from the physicochemical and motif analyses are reported in this section. 
The sequences are referred to in their common names. 
3.3.1 MOTIF ANALYSIS 
Motif analysis allows a powerful means of determining protein function (Hodgman, 1989). In 
this study the motifs from both the catalytic domain and the full length sequences were analyzed 
using MEME and their conservation was visualized using a heat map (Figure 3.1A and B) 
generated through Python scripting as the MEME output could not be used for informative 
visualization. 
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MEME generated a total of 98 and 75 motifs from the full sequences and the catalytic domain 
respectively (Fig. 3.1A and B). The motifs are represented according to conservation, 6 common 
conserved motifs were observed in both the full length sequences and the catalytic domain.  
3.3.1.1     FULL LENGTH SEQUENCE MOTIF ANALYSIS 
MEME generated a total of 98 motifs from the full length sequences (Figure 3.1A). Six 
thoroughly conserved motifs were discovered namely; motifs 1, 2, 3, 6, 8 and 12. There were 
other motifs that were absent from the sequences of the homolog structures suggesting that the 
motifs were conserved in the prodomain these were motifs 5 and 7. Motif 5 represents GNFD 
motif while motif 7 represents the ERFNIN motif; both are required in the folding and 
stabilization of the prodomain with salt bridges which are essential in the inhibition of the mature 
domain by the prodomain (Pandey et al. 2009). Motif 7 was observed to be absent from the O-
cathepsins, they displayed the pattern S(A/G)R/EFSHN instead of the common ERFNIN motif 
however the motif serves the same purpose as the ERFNIN motif. This suggests that the O-
cathepsins prodomain might fold in a unique way and the mature domain inhibition by the 
prodomain could occur differently although further studies would have to be conducted to 
confirm this. The motif analysis also revealed 2 unique motifs only found in the Plasmodium 
species with the exception of FP-1, the LMNNLESVN and the motifs suggesting that it could be 
vital in the function of the Plasmodium proteases. The motif is thought to form the prodomain 
insert region that facilitates the prodomain inhibition (Korde et al. 2008). As discussed earlier 
(section 2.3.3) FP-1 diverged from the other Plasmodium species suggesting that it is distantly 
related to them. The motif analysis confirmed this observation as it showed that FP-1 lacked 
motifs common in other Plasmodium proteases that were vital in their function.  
3.3.1.2   CATALYTIC DOMAIN MOTIF ANALYSIS 
The same 6 motifs that were conserved across all the sequences including the sequences of the 
homolog structures observed in the full length sequence (Figure 3.1A) were also observed in the 
catalytic motif analysis (Figure 3.1B). Since MEME identifies motifs regardless of their 
biological significance the conserved motifs were mapped onto the FP-2 structure and their 
position compared to that of the sub-sites essential for catalytic activity to determine their 
functional importance (Figure 3.2).  
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Figure 3.2 Sub-site residues and motif mapping onto the FP-2 structure (2OUL). A) The catalytic residues are 
shown in yellow spheres while sub-site 1 is shown in wheat, sub-site 1’ is in green, sub-site 2 is shown in magenta 
and sub-site 3 is shown in blue. The rest of the protein is shown in slate blue.  B) The conserved residues are shown 
in green, the Plasmodium unique motifs are shown in red and the motif that differs from the Leishmania species is 
shown in purple 
When compared to the sub-site residues map, 5 of the 6 conserved motifs were found to be 
located in the sub-site regions suggesting that the motifs are conserved in order to maintain the 
activity of the proteases. Interestingly there was another conserved motif found in the region next 
to the FP-2 nose-like protrusion (shown in cyan in Figure 3.2B and motif 6 in Table 3.1). The 
motif is known to play a vital role in the folding of the protease by stabilizing the initial 
interactions of the folding process (Wang et al. 2006). However, despite the conservation of this 
motif, in Plasmodium species this motif is not sufficient to facilitate the folding of the protease 
hence the presence of the nose-like protrusion only found in Plasmodium species (Pandey et al. 
2009).  
The positions and sequence logos of the conserved motifs in both the catalytic domain and the 
full length sequences were summarized and illustrated (Table 3.1).  
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Table 3.1 A summary of the conserved motifs in both the catalytic domain and the full length sequences of the 
cysteine proteases according to the MEME HTML output. The background shading indicates the colour of the motif 
in the mapping (Figure 3.2B). The motif positions on the sequence indicate the range of positions across all the 
sequences.  
 
Motif number 
 
Sequence position 
 
Sequence Logos 
 
 
1 
 
 
12 -70 
 
 
 
 
 
2 
 
 
180 - 230 
 
 
 
 
 
3 
 
 
118 – 155 
 
 
 
 
 
5 (6 in full length 
sequence analysis) 
 
 
154 - 182 
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 6 (8 in full length 
sequence analysis) 
 
 
 
1 – 25 
 
 
 
 
 
 
11 (12  in full length 
sequence analysis) 
 
 
60 - 83 
 
 
 
 
3.3.1.3    UNIQUE CATALYTIC DOMAIN MOTIFS 
The motif analysis of the catalytic domain also revealed motifs that were unique to certain 
species. The Plasmodium species unique motifs were observed as shown in a red box in Figure 
3.2B, however within the Plasmodium species it was noted that FP-1 did not share the common 
motifs as other Plasmodium proteases and it had its own motifs and this observation is explained 
by the clustering of the Plasmodium proteases in the phylogenetic tree (Chapter 2, Figure 2.5) in 
which FP-1 diverges from the rest of the Plasmodium species. The conserved motif 14 in the 
Plasmodium species forms the nose-like protrusion which is necessary for correct folding of the 
protease. This motif was absent in FP-1 which is a distantly related protease to the other 
Plasmodium proteases and studies have shown that adding the sequence that forms the nose-like 
structure to FP-1 results in the lack of enzyme activity of FP-1 due to the fact that the residue 
Glu-20 that mediates the folding is absent in FP-1 as well as other related proteases. Also within 
the Plasmodium species the falcipains were observed their unique motif (motif 19) which 
interestingly forms the arm-like protrusion in the structure. Motif 19 is located on the distal end 
of the right side of the protease. Since the motif is located at a distance greater than 25 Å from 
the active site it is thought to participate in hemoglobin binding (Pandey & Dixit 2012). It is not 
clear how hemoglobin binding occurs in the other Plasmodium proteases but it can be inferred 
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that the unique motifs observed in the murine and other human malarial proteases could 
participate in hemoglobin binding.  
The Leishmania species were also shown to exhibit unique motifs shown in a purple box in 
Figure 3.2B. The Leishmania motifs could not be mapped onto a structure to infer the possible 
role of the motifs as there is currently no available crystal structure. However in future studies 
the Leishmania structures can be modelled and the unique motifs mapped to elucidate their role 
and the results confirmed with wet laboratory assays.  
The Trypanosoma and T.gondii species each had unique motifs shown in green and black boxes 
respectively (Figure 3.2B) and these were successful mapped onto the available structures. The 
T.gondii unique motifs 38 and 45 are located in the distal end of the right domain of the protease 
and their role during the infective cycle is not clear, however motif 48 is known to participate in 
the folding of the protein (Kim, 2004). When the Trypanosoma unique motifs were mapped onto 
the cruzipain structure (1ME4) and they were not located in functionally relevant regions 
suggesting that the species shares functional motifs with other cysteine proteases such as motif 
13 which makes up sub-site 2, the region that governs substrate specificity. This could also infer 
that the Trypanosoma species in this study each have their own motifs that define their structure 
and function.  
The heat map also supported the results obtained from phylogenetic analysis discussed in 
Chapter 2 as each type of cathepsins had their own unique motifs which could be explained by 
the observation that they clustered together in the phylogenetic tree regardless of the organism 
they came from (Chapter 2, Figure 2.5). The unique motifs mainly found in the parasites were 
reported and summarized (Table 3.2). 
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Table 3.2 A summary of the species cysteine proteases’ unique motifs according to the MEME HTML output. The 
motif positions on the sequence indicate the range of positions across all the sequences. 
Motif number Species name Sequence 
position 
Sequence Logos 
 
Motif 4 
All except the 
protozoan parasites 
and cathepsin O 
 
68 - 111 
 
 
 
 
Motif 7 
 
 
All except 
Trypanosoma, 
Leishmania, 
Cathepsin F and O 
 
 
140 -169 
 
 
 
 
Motif 8  
 
All except murine 
Plasmodium  
 
214 - 248 
 
 
 
 
 
Motif 10 
 
 
All except Protozoan 
parasites, Cathepsin 
L, F and W 
 
 
94 - 134 
 
 
 
 
 
Motif 16 and 39 
 
 
Murine Plasmodium  
 
219 -239 
 
182 - 196 
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Motif 19 
 
Falcipains except 
Falcipain 1 
 
182 -196 
 
 
 
 
Motif 34 
 
Human Malarial 
Plasmodium 
 
218 - 226 
 
 
 
 
Motif 39 and 64 
 
Trypanosoma  
182 – 196, 236 - 
337 
 
See appendix 
 
Motif 43,53,56-58 
 
Falcipain-1 
83 – 93, 191 - 198, 
110 - 119, 1 - 6, 96 -
101 
 
See appendix 
 
Motif 16, 18, 23 
and 52 
 
Leishmania 
115 – 135, 212 – 
232, 3 – 13, 107 - 
114 
 
See appendix 
Motif 37, 38, 45 
and 48 
 
T,gondii 
110-115, 212 – 217, 
184 – 189,  9 -14 
 
See appendix 
 
Motif analysis on its own is insufficient in providing a conclusion about the distinct patterns 
among the studied proteases. Therefore to further elucidate and understand the differences it is 
ideal to zoom into the sequences and evaluate the physicochemical properties and well as the 
amino acid composition since protein characteristics are influenced by the residues within the 
sequence. 
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3.3.2 PHYSICOCHEMICAL PROPERTIES ANALYSIS 
To understand protein function diversity, it is vital to understand physicochemical properties of 
the constituent amino acids, even though physicochemical properties go beyond the mere sum of 
properties of the various component amino acids (Cozzone 2002). It is possible to infer protein 
diversity within the same family of proteins based on their different physicochemical properties 
and in this study these properties were calculated for all the retrieved sequences (Appendix A-I). 
The results were averaged for each group and the summary tabulated (Table 3.3). 
Table 3.3 A summary of all the calculated physiochemical properties of the catalytic domain of the parasites, 
vectors and hosts cysteine proteases using BioPython. The blue background indicates the properties of parasites 
group while the red background indicates the vectors group and the green background highlights the hosts group. 
 
Property 
Parasites Vectors Hosts 
Mean  SD Mean  SD Mean SD 
Aromaticity 0.112 ±0.025 0.114 ±0.008 0.115 ±0.009 
GRAVY -0.269 ±0.187 -0.390 ±0.159 -0.404 ±0.154 
PI 5.168 ±0.863 6.486 ±1.330 7.210 ±1.437 
Instability index  37.290 ±9.459 27.039 ±6.584 29.017 ±6.584 
Mr (kDa) 28.601 ±3.804 25.033 ±0.983 25.664 ±1.429 
 
All the groups seem to have similar aromaticity indices of about 0.11 and very low standard 
deviations which show that they have the same content of the aromatic residues. However the 
GRAVY summary showed negative averages indicating that the proteins are hydrophilic 
although the standard deviations were quite high meaning that in each of the groups there is 
variation in the GRAVY values therefore there is a need to observe the data distribution more 
closely. When observing the pI of each of the groups there was a distinct difference in the 
results. The parasite group showed a pI of 5.168 while the vectors and hosts showed a pI of 
6.486 and 7.210 respectively indicating that the different groups have minimal solubility at 
varying pH and the low respective standard deviations show that most of the data in each of the 
groups did not vary significantly. The pH values indicate the organisms in each group had 
overlapping pH where they can be purified for further analysis in a wet laboratory. The 
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instability indices for each of the groups was below 40 showing that the proteins across all the 
groups have long half-lives therefore they are stable, however there are large standard deviations 
that were observed which illustrate that in as much as most of the proteins were stable with an 
instability index below 40 there is variation in the data distribution. Finally the molecular weight 
calculations showed that the vector and host groups have similar weights of about 25 kDa while 
the parasite group is slightly larger with a weight of 28.601 kDa. The standard deviations are low 
meaning that there is little variation in the molecular weight values.  
3.3.2.1    CATALYTIC DOMAIN AND FULL LENGTH SEQUENCE GRAVY 
ANALYSIS 
Based on the amino acid sequence alone it is possible to determine whether a segment or the 
entire protein is hydrophobic or hydrophilic in nature through GRAVY calculations. The 
hydropathicity of a protein provides insight in the nature of interactions and ligands that can 
interact with the protein (Kyte & Doolittle 1982).Hydropathicity evaluates the hydrophobicity or 
hydrophilicity of a protein. The greater the hydropathic index the more hydrophobic the protein 
and the more negative the index the more hydrophilic the protein is. 
The aim of this study is to compare the physicochemical properties of different groups hence box 
plots are the most appropriate method of showing the data.  Boxplots show and compare the 
distribution of the properties’ values in quarters. The lower quartile shows the value below which 
25% of the data is contained while the upper quartile shows the value above which 25% of the 
data is contained. The box plot also shows the median value within the range of data as well as 
the outliers which are defined as any data point that is calculated 1.5 the interquartile range 
whether below the lower quartile or above the upper quartile.  
In this study the GRAVY calculations were visualized using boxplots and the levels of 
hydropathicity in the proteins evaluated (Figure 3.3). 
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Figure 3.3 Box plots showing the GRAVY data of the full length sequences (A) and the catalytic domain (B) of the 
parasites, vectors and host cysteine proteases shown in red, wheat and green respectively. GRAVY is calculated by 
adding the hydropathic value for each residue and dividing by the length of the sequence. 
A direct observation of the boxplots showed that most of the data was in the negative range 
indicating that the proteases interact well with water. The boxplot medians in the full length 
sequences were at the same point while those of the catalytic domain of the host and vectors 
differed from that of the parasites. This suggested that in full length sequences all the data had 
the same distribution and the variations noted were expected in samples, whereas in the catalytic 
domain the host and vector samples were not so different from each other but differed from the 
parasites group. When the Kruskal-Wallis test was performed and it returned a p-value of 0.84 
and 0.02254 for the full length sequences and the catalytic domain respectively. Since the p-
value of the full length sequences was higher than the alpha level 0.05, there was insufficient 
evidence to reject the null hypothesis therefore concluding that all the full length sequences are 
the same while the catalytic domain sequences have significant variation since their p-value was 
lower than the alpha level. To confirm the differences between the catalytic domain and the full 
length sequences the Kruskal-Wallis test was used and it returned a p-value of 0.06003, a value 
above 0.05 suggesting that since there is no significant difference between the full length 
sequences and the catalytic domain hence the prodomain in the full sequences does not affect the 
hydropathicity of the proteases.  
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3.3.2.2      CATALYTIC DOMAIN AND FULL LENGTH SEQUENCE 
AROMATICITY ANALYSIS 
In a number of studies aromatic residues have been implicated in forming aromatic interactions 
within the protease for stabilization or with the substrate (Lanzarotti et al. 2011). Aromatic 
interactions can only occur in the presence of aromatic residues hence in this study the relative 
frequencies of the aromatic residues in the retrieved sequences were investigated and illustrated 
using a box plot (Figure 3.4). 
 
Figure 3.4 Box plots showing the aromaticity data of the full length sequences (A) and the catalytic domain (B) of 
the parasites, vectors and host cysteine proteases shown in red, wheat and green respectively. The aromaticity index 
is determined by the relative frequencies of the aromatic amino acids, phenylalanine (Phe), tyrosine (Tyr) and 
tryptophan (Trp) within the sequences. 
In the full length sequence boxplot (Figure 3.4A) the medians were not at the same point 
implying that the samples might be different, however when the Kruskal-Wallis test was 
performed it returned a p-value of 0.1965 which is above the alpha level 0.05 suggesting that the 
variability in the positions of the medians showed mere differences that are expected within 
populations.  
The medians observed from each of the groups in the catalytic domain boxplots are virtually at 
the same point suggesting that the data follows the same distribution (Figure 3.4B). To confirm 
this observation the Kruskal-Wallis test was used and it returned a p-value of 0.9359. Since the 
returned p-value was greater than 0.05 as the hypothesis testing is done 95% level of 
significance, there was insufficient evidence to reject the null hypothesis that states that the data 
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follows the same distribution. Therefore it could be concluded that the proteins in each of groups 
have the same content of aromatic residues.  
When the full length sequences aromaticity was compared to that of the catalytic domain the 
medians were virtually at the same point although the distribution of the catalytic domain of the 
host and vectors was not as wide as that of the full length sequences. When the test statistic was 
applied a p-value of 0.6209 was obtained hence it could be concluded that there is no difference 
in aromaticity of the full length sequences and the catalytic domain hence the despite the 
presence of the prodomain in the full length sequences it does not affect the protease aromaticity 
suggesting that the prodomain is not rich in aromatic residues. This is probably due to the fact 
aromatic residues stabilize proteins and since the prodomain is eventually degraded to activate 
the protease it does not need to be highly stable to avoid an energy expensive proteolysis of the 
prodomain. 
3.3.2.3     CATALYTIC DOMAIN AND FULL LENGTH SEQUENCE 
INSTABILITY INDEX ANALYSIS 
The ability of a protein to retain its activity and structural conformation was evaluated by 
calculating the instability index of both the full length sequences and the catalytic domain. The 
distribution of the instability indices was visualized using box plots (Figure 3.5).  
 
Figure 3.5 Box plots showing the instability index data of the full length sequences (A) and the catalytic domain 
sequences (B) of the parasites, vectors and host cysteine proteases shown in red, wheat and green respectively. The 
instability index is calculated by evaluating the N-terminal residue. 
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In the full length sequences box plot the groups’ data had varying distribution patterns, the 
parasites group instability indices varied from 20 to above 50 while vectors groups’ indices were 
between 30 and 40 suggesting that most of the proteases in the group had the same stability with 
the exception of the G.gallus cathepsin K which was above 40. The hosts’ group data ranged 
from 30 to 45 almost like that of the vectors. When the test statistic was applied it returned a p-
value of 0.2166 suggesting that even though the data was distributed differently in each group, 
the proteases had the same stability. 
The parasite group median was positioned above that of the vectors and hosts meaning that the 
host and vector proteins have similar instability indices (Figure 3.5B). The parasites group 
showed some unstable proteins that had an instability index above 40 namely the Leishmania, 
T.gondii and P.chabaudi species. The Kruskal-Wallistest returned a p-value of 0.002742 which 
was less than 0.05 therefore the null hypothesis stipulating that the data had the same 
distributions was rejected and there was variation in the groups’ instability index. The Kruskal-
Wallis test was also performed on the host and vector groups to confirm that indeed the proteins 
had similar distributions. The test returned a p-value of 0.84 therefore failing to reject the null 
hypothesis hence the host and vector groups have similar distributions. When comparing the full 
length sequences to the catalytic domain the host and vector groups had much lower medians 
suggesting that the catalytic domain is more stable than the entire full sequence. Interestingly the 
parasite medians in both plots remained the same meaning that the stability of the catalytic 
domain and the full length sequence could be the same. When the Kruskal-Wallis test was 
applied a p-value of 4.674e-05 was obtained therefore it could be concluded that the stabilities of 
the catalytic domain and the full length sequences were different and by observation of the box 
plots (Figure 3.5) the catalytic domain is more stable than the full length sequences. It could be 
inferred that the prodomain affects the stability of the proteases and without it the proteases are 
more stable. 
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3.3.2.4     CATALYTIC DOMAIN AND FULL LENGTH SEQUENCE 
ISOELECTRIC POINT ANALYSIS 
To further establish the differences between the proteases the environments at which they have 
minimal solubility were established through pI calculations and these were visualized using a 
box plot (Figure 3.6). 
 
Figure 3.6 Box plots showing the isoelectric points of the full length sequences (A) and the catalytic domain (B) of 
the parasites, vectors and host cysteine proteases shown in red, wheat and green respectively.  
In Figure 3.6A the host and vector medians were at the same point suggesting they had similar pI 
of about 7. However they had varying distributions the hosts group had a much wider 
distribution suggesting that the proteases within the group had varying pI, ranging from about 5 
to 11. The parasites group had a much lower median and a distribution range below 7. When the 
test statistic was performed it gave a p-value of 0.008671 meaning that the protease groups have 
varying pI.  
In Figure 3.6B the groups showed a difference in the median positions also illustrating that each 
of the groups had different pI. This was confirmed by performing a Kruskal-Wallis test which 
returned a p-value of 2.679e-05 which was interpreted as indicating that there is a significant 
difference between the pI of the groups. From direct observation of the plot it can be seen that 
the host and vectors groups are have minimal solubility in the acidic range although the parasitic 
proteases have much lower pI. The vectors group showed that they have minimal solubility pH 
range from 5 to 9.  
69 
 
When the full length sequences plot was compared to that of the catalytic domain the pI of the 
hosts and vectors in catalytic domain plot were much lower (Figure 3.6). The vectors group was 
basic in the full length sequences plot seemed to be acidic in the catalytic domain. Although the 
hosts’ median in both plots was at the same point the distribution narrowed in catalytic domain 
from a range of pH 5 to 11 to a range of pH 5 to 9. The differences were assessed using the 
Kruskal-Wallis test that returned a p-value of 2.804e-07 indicating that there is a significant 
difference between the two groups which could be interpreted as that the prodomain plays a role 
in the solubility environment of the proteases. 
After determining the various properties of the proteases it was crucial to understand the amino 
acids underlying the varying physicochemical properties. Consequently an amino acid 
composition analysis was performed and reported in the next section.   
3.3.3  AMINO ACID COMPOSITION ANALYSIS 
3.3.3.1    CATALYTIC DOMAIN ANALYSIS 
The amino acid composition of proteins gives them their distinct features and properties. The 
physiochemical properties discussed in section 3.3.2.2 are a result of the amino acid residues 
present in the proteases. In this study the amino acid compositions for each group were 
investigated and visualized using bar plots generated from MATLAB (Figure 3.7). 
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The host and vector sequences were observed to have similar patterns of amino acid 
compositions. There were no distinctions between the host and vector groups. This could have 
been due to the fact that the host and vector sequences do not cluster according to the organisms 
they come from but rather the type of cathepsins they are. The patterns that were observed 
between the host and vector groups followed the clustering pattern in the phylogenetic analysis 
(section 2.3.3). The cathepsin H proteases seemed to favour the alanine residues while the 
cathepsins L and F favoured the threonine residues (Figure 3.7A and B). 
 The parasites group was observed to favour less alanine, phenylalanine and asparagine but 
preferred threonine. The Trypanosoma and Leishmania species were observed to favour 
threonine relative to other parasite sequences. The Plasmodium species preferred the hydrophilic 
glutamine residues and less hydrophobic alanine residues. The Leishmania and Trypanosoma 
residues were observed to favour hydrophobic residues unlike the Plasmodium species which 
favoured the hydrophilic residues and the negatively charged glutamic acid and aspartic acid. In 
Figure 3.7 3D bar plots showing the catalytic domain amino acid composition in hosts (A), vectors (B) and parasites 
(C) cysteine proteases generated in MATLAB. The individual residues, sequences and the amino acid frequencies 
are illustrated on the x, y and z axis respectively. The hydrophobic residues are shown in red while the hydrophilic 
residues are shown in blue. The negatively charged residues are indicated orange and the positively charged residues 
are shown in green. 
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as much there were distinct patterns that were observed among and within the parasite group 
their catalytic significance could not be inferred therefore it was important to do a sub-site 
analysis.  
3.3.3.2     SUB-SITES ANALYSIS 
3.3.3.2.1     SUB-SITE 1 ANALYSIS 
Sub-site 1 is the least defined of all the sub-sites and it does not contribute much to substrate 
specificity, however it is the region that initiates catalysis therefore there is a need to understand 
the amino acids present in each group that participate in initiating catalysis (Sabnis et al. 2003). 
The sub-site 1 amino acid compositions are also illustrated using a bar plot (Figure 3.7). 
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Figure 3.8 3D bar plots showing the sub-site 1 amino acid composition in hosts (A), vectors (B) and parasites (C) 
cysteine proteases generated in MATLAB. The individual residues, sequences and the amino acid frequencies are 
illustrated on the x, y and z axis respectively. The hydrophobic residues are shown in red while the hydrophilic 
residues are shown in blue. The negatively charged residues are indicated orange and the positively charged residues 
are shown in green. 
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Sub-site 1 is very well conserved throughout all the groups; glutamine is conserved as it plays a 
role in stabilizing the oxyanion intermediate during substrate catalysis (Sabnis et al. 2003).  This 
region is primarily hydrophilic as it is located in the exterior of the protein where it interacts with 
the substrate solvent.  
3.3.3.2.2 SUB-SITE 1’ ANALYSIS 
Sub-site 1’ is known not to be the primary site of substrate specificity however the variations in 
amino acid compositions in the parasite, host and vector groups could generate notable activity 
differences. In this study the variations in this region were investigated and the results displayed 
in a bar plot (Figure 3.9). 
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Figure 3.9 3D bar plots showing the sub-site 1’ amino acid composition in hosts (A), vectors (B) and parasites (C) 
cysteine proteases generated in MATLAB. The individual residues, sequences and the amino acid frequencies are 
illustrated on the x, y and z axis respectively. The hydrophobic residues are shown in red while the hydrophilic 
residues are shown in blue. The negatively charged residues are indicated orange and the positively charged residues 
are shown in green. 
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From the direct observation of the plots it can be observed that they have similar hydrophobic 
and hydrophilic distributions. The host and the vector groups (Figure 3.8A and B) are more 
negatively charged relative to the parasites group.  
In the hosts group the same pattern observed in the phylogenetic analysis and motif analysis 
(section 3.3.1.2) was observed (Figure 3.8B). Cathepsins of the same types had similar amino 
acid compositions. F, K and O cathepsins share the same preferences; they all favour the alanine 
residue. Whereas the L-cathepsins prefer the negative charged aspartic acid. The W and H 
cathepsins prefer methionine and tyrosine respectively instead of alanine. The S-cathepsins 
favour the glycine residue. It can therefore be inferred that these patterns imply activity 
differences within the cathepsins.  
In the vectors group a similar pattern was observed as the O, F and K cathepsins favour alanine 
with the exception of G.gallus-O (Figure 3.8B). On the contrary the H-cathepsins favour tyrosine 
instead of alanine and the L-cathepsins favour aspartic acid, serine and alanine with the 
exception of A.darlingi which favour isoleucine. From this observation it can be noted that the 
H-cathepsins are different from the rest of the other cathepsins as they do not favour alanine.  
In the parasites group (Figure 3.8C) FP-2A and FP-2B like FP-1 and the murine malarial 
proteases favour the tyrosine residues although FP-1 also favours serine better than any other of 
the proteases within the same group, whereas the FP-3, KP-2 and VP-2 favour alanine.  
In sub-site 1’ there are noted differences in size and hydrophobicity considering that residues 
such as alanine and glycine have a much smaller mass relative to other residues hence the 
proteases that favour them are likely to have smaller sub-site 1’. Tryptophan is conserved in all 
groups as it is the residue that stabilizes the substrate through hydrophobic interactions (Sabnis et 
al. 2003).  
3.3.3.2.3 SUB-SITE 2 ANALYSIS 
Sub-site 2 is the primary site of substrate preference therefore it is the region that arouses a lot of 
interest in designing highly selective inhibitors (Alves et al. 2003). It is for this reason that the 
amino acid composition analysis was performed at sub-site 2. The 3D plots generated from 
MATLAB are used to illustrate the analysis (Figure 3.6). 
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Figure 3.10 3D bar plots showing the sub-site 2 amino acid composition in hosts (A), vectors (B) and parasites (C) 
cysteine proteases generated in MATLAB. The hydrophobic residues are shown in red while the hydrophilic 
residues are shown in blue. The negatively charged residues are indicated orange and the positively charged residues 
are shown in green. 
At sub-site 2 it was observed that the site is primarily hydrophobic with conserved tryptophan 
and glycine residues that are known to form hydrophobic interactions with the ligand. In the 
parasites group the FP-2A, 2B and 3 were found to favour more lysine residues, this was 
interesting as the lysine residues are known to occupy the bottom of the falcipain binding pocket 
influencing the size of the pocket and consequently the type of ligand that can bind in the pocket. 
The Leishmania species were noted to favor the hydrophilic tyrosine residues unlike the other 
protozoan parasites that favour the hydrophobic alanine residues which are known to play a role 
in substrate preferences. Thus the Leishmania residues are relatively more hydrophilic. The 
Entamoeba species seemed to favour the positive charged histidine residue while the human 
malarial Plasmodium species favour the methionine residues. The Leishmania, Trypanosoma and 
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the murine Plasmodium species were observed to be more hydrophilic relative to the human 
Plasmodium species.  
In the hosts group the human proteases were observed to be the most hydrophobic when 
compared to the other host organisms. Both the host and vector groups were more positively and 
negatively charged while the parasites group was relatively more hydrophobic. 
3.3.3.2.4      SUB-SITE 3 ANALYSIS 
This is the glycine-rich region that is known to aid in the orientation of the substrate through 
hydrophobic interactions. Sub-site 3 also participates in substrate recognition and has little 
substrate discrimination (Sabnis et al. 2003). The variations in amino acid compositions in all the 
groups was investigated and shown using a 3D bar plot (Figure 3.10). 
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The host sub-site 3 is primarily hydrophobic with alanine being the most conserved residue. The 
O-cathepsins were observed to favour alanine more than any of the proteases as well as leucine 
and methionine. The W and S cathepsins favour aspartic acid while the F-cathepsins favour 
tyrosine. 
In the vectors group sub-site 3 was also observed to be also hydrophobic with valine and tyrosine 
residues being conserved. This region was also observed to favour alanine and serine. The W-
cathepsins were observed to favour negatively charged aspartic acid whereas the F, W and O-
cathepsins were observed to be the glycine rich proteases.  
The parasites group was observed to be hydrophobic as the cathepsins appeared to favour alanine 
and phenylalanine. The murine cathepsins were observed to favour the alanine residues while 
T.gondii-L favours phenyalanine. FP-1, 2A and 2B, the Trypanosoma species favour the 
asparagine unlike the Leishmania species which favour glutamine. Of all the proteases in this 
group FP-1 preferred leucine and lysine instead of alanine and phenyalanine preferred by the rest 
of the proteases in this group. The Trypanosoma and Leishmania cathepsins are the only 
hydrophilic ones in the parasite group suggesting that their sub-site 3 is most likely to recognize 
polar substrates while the rest of the proteases recognize non-polar substrates.  
Of all the groups in this analysis the vectors group is the only group that favours tyrosine and 
valine. The studied cathespsins are observed to be hydrophobic with the exception Trypanosoma 
and Leishmania cathepsins which are hydrophilic. There are notable differences in amino acid 
preferences thus demonstrating sub-site 3 binding pockets vary in size from one cathepsin type to 
another.  
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    CHAPTER FOUR  
4. CONCLUSIONS AND FUTURE WORK 
This study is a step towards elucidating the differences as well similarities in the primary 
structure and physicochemical properties of the protozoan parasites, their host and  vector 
cysteine protease catalytic domains; which are essential in understanding the activity of the 
proteases. Considering cysteine proteases are validated viable drug targets in protozoan 
infections, this study is vital in drug design since limited knowledge of these differences or 
lack thereof has resulted in drug toxicity. This study sought to answer the question: Are 
there any primary structure and physicochemical differences or similarities between the 
catalytic domains of cysteine proteases of protozoan parasites and their respective hosts and 
vectors, which play a role in the protease activity and/or substrate preferences? 
 
In the initial stage of the study 62 L-like cathepsin sequences were retrieved and classified in 
three groups, the hosts, vectors and parasites. The phylogenetic analysis showed that the 
cathepsins in the host and vector groups clustered according to their cathepsins instead of the 
organisms they came from while in the parasites group they clustered according to their 
organisms. The motif analysis confirmed these observations as the same cathepsin types in the 
host and vector groups shared unique motifs whereas each parasite organisms had their own 
unique motifs. These unique motifs were observed to occur in the regions outside the catalytic 
zone. Motif analysis also showed 6 conserved motifs across all organisms, 5 of which were in the 
catalytic region while the sixth one is involved in protein folding away from the catalytic region. 
These observations did not contribute to the final conclusions.  
The physicochemical analysis showed that the cathepsins studied had similar aromaticity and pI. 
The parasite cathepsins are less stable and larger in molecular weight relative to the host and 
vector cathepsins. The GRAVY scores also revealed that the parasites group was more 
hydrophobic. This revelation was confirmed by the amino acid composition analysis which 
showed a higher content of hydrophobic residues relative to the host and vector groups. 
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The amino acid acid analysis was particularly useful and informative. It showed that sub-site 1 is 
well conserved unlike sub-site 2 which is highly variable although the residues involved in 
hydrophobic interactions remained conserved. The sub-site 2 variability aroused interest as this 
is the region that is responsible for ligand specificity and preference. This observation sheds light 
on the ligand preferences of the various groups. There variations mainly occurred in the residues 
that line the bottom of the sub-site 2 binding pocket thus influencing the size of the binding 
pocket and the ligand that can be accommodated during catalysis. It can be inferred that the 
cathepsins use size as means to select their ligands. For instance within the parasites group there 
were also distinct patterns, the falcipains with the exception of FP-1 favoured the lysine which 
could suggest that the binding pocket of these species is much wider hence it can accommodate 
ligands of a much bigger size relative to the other protozoa parasites. The Leishmania species 
was noted to favour the hydrophilic tyrosine residue instead of alanine which plays a role in 
ligand preference hence we could conclude that the Leishmania species would probably prefer 
polar-based ligands while the other parasites prefer hydrophobic ligands. The host and vector 
groups were also noted to be negatively and positively charged while the parasite group is more 
hydrophobic, these observations ould possibly play role in ligand specificity as the parasite 
cathepsins would prefer non-polar ligands while the host and vector cathepsins would prefer 
charged ligands.  
As stated earlier this study aimed to identify the primary structure and physicochemical 
properties differences and similarities within the host, vector and parasite groups’ cysteine 
proteases. Having identified the differences and similarities the next step is to undertake a 
physicochemical analysis of each of the sub-site regions and validate them with an appropriate 
test statistic that takes into account the short sequence lengths of the sub-site regions. The ligand 
preferences concluded from this study can be further studied through structure-based virtual 
screening of the suggested ligand types from available inhibitor libraries. The protozoan cysteine 
protease structures that are not currently available can be modelled through homology modelling 
using available structures from other protozoans as templates to facilitate the structure-based 
virtual screening process.  
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This study has offered a perspective on the ligand preferences of the protozoan parasites’ 
cysteine proteases compared to their hosts and vectors by evaluating the protease 
physicochemical properties and statistically validating them using the Kruskal-Wallis test. As a 
direct result of the methodology the differences in this study are among the three groups thus a 
statistical analysis such as Kolmogorov-Smirnov test can be used to identify the group that is 
different from the rest by using combinations of two for the three groups.  
Current inhibitors for cysteine proteases in protozoan parasites lack selectivity and specificity 
resulting in drug toxicity. Therefore this study shows promise in the design of specific anti-
protozoan inhibitors that can be designed by exploiting the parasite preferences elucidated in this 
study particularly in the sub-site 2 region.  
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APPENDIX 
APPENDIX A:  DATA RETRIEVAL, SEQUENCE ALIGNMENT AND 
PHYLOGENETIC ANALYSIS 
I .The summary of the retrieved sequences showing the accession number, E-value, sequence 
identity and query cover to the query sequence FP-2. 
Species name Accession 
number 
Common 
name  
E-
value 
% 
Identity 
%query 
cover 
Positives Gaps Score 
P.falciparum 3BWK_A Falcipain-3 2.60E-
59 
68 - 98 - 394 
P.falciparum 
3D7 
2OUL_A cysteine 
protease 
1.60E-
68 
98 - 99 - 450 
S.scrofa 8PCH_A Cathepsin H 9.20E-
53 
40 - 95 - 348 
T.gondii RH 3F75_A Cathepsin L 8.20E-
53 
40 - 96 - 349 
M.musculus 
(house mouse) 
4BS6_A Cathepsin S 1.40E-
54 
38 - 94 - 361 
Homo sapiens 1BY8_A Procathepsin 
K 
8.40E-
55 
40 - 68 - 379 
Homo sapiens 2XU3_A Cathepsin L 6.10E-
54 
37 - 96 - 356 
Homosapiens AAH02642.1 Cathepsin S 8.00E-
41 
32 92 49 11 153 
Homosapiens AAL23961.1 Cathepsin H 4.00E-
49 
35 89 51 12 176 
Homo sapiens NP_000387.1 Cathepsin K 4.00E-
47 
34 92 53 10 171 
Homo sapiens AAH12612.1 Cathepsin L 3.00E-
46 
32 66 54 12 168 
B.taurus NP_001029607.1 Cathepsin K 8.00E-
49 
35 90 52 10 174 
B.taurus NP_001028787.1 Cathepsin S 1.00E-
40 
32 91 49 11 151 
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B.taurus NP_001029557.1 Cathepsin H 8.00E-
47 
34 89 51 12 169 
B.taurus NP_776457.1 Cathepsin L2 7.00E-
47 
32 90 53 11 169 
M.musculus AAD32136.1 Cathepsin L 5.00E-
45 
32 91 52 12 164 
M.musculus NP_031828.2 Cathepsin K 3.00E-
50 
34 92 52 10 179 
M.musculus AAC05781.1 Cathepsin S 5.00E-
41 
32 89 50 11 154 
M.musculus AAG28508.1 Cathepsin F 2.00E-
33 
34 60 48 10 134 
M.musculus AAH06878.1 Cathepsin H 3.00E-
50 
34 93 52 11 179 
G.gorilla XP_004026652.1 Cathepsin K 1.00E-
47 
34 65 53 10 170 
G.gorilla XP_004056662.1 Cathepsin H 9.00E-
49 
34 65 51 12 173 
G.gorilla XP_004051582.1 Cathepsin W 1.00E-
35 
28 61 49 9 137 
P.paniscus XP_008952375.1 Cathepsin F 4.00E-
38 
33 66 48 10 139 
P.paniscus XP_003828695.1 Cathepsin W 1.00E-
37 
28 61 49 9 138 
P.paniscus XP_003820654.1 Cathepsin L2 5.00E-
47 
33 65 51 10 163 
P.paniscus XP_003822607.1 Cathepsin O 6.00E-
34 
34 53 50 14 126 
P.troglodytes XP_001170363.1 Cathepsin W 2.00E-
35 
28 61 49 9 137 
P.troglodytes XP_517502.2 Cathepsin O 6.00E-
32 
34 53 50 14 126 
P.troglodytes XP_003312197.1 Cathepsin L1 1.00E-
46 
32 65 54 12 168 
T.gondii ABY58967.1 TgCathepsinL 2.00E-
59 
35 75 52 9 205 
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L.aethiopica AEE42617.1 cysteine 
protease 
1.00E-
50 
35 64 53 8 181 
L.mexicana CAA78443.1 cysteine 
protease 
6.00E-
43 
32 61 51 8 160 
L.major AFN27092.1 cysteine 
protease 
5.00E-
49 
34 81 52 8 175 
L.tropica AFN27126.1 cysteine 
protease 
3.00E-
49 
35 64 52 8 178 
T.brucei CAC67416.1 Rhodesiense 4.00E-
43 
34 61 50 9 161 
T.cruzi AAB41118.1 Cruzipain 2.00E-
44 
34 61 50 10 164 
P.berghei 
ANKA 
XP_680416.1 Berghepain-2 2.00E-
135 
45 100 64 3 402 
P.yoelii yoelii 
17XNL 
XP_726900.1 Yoellipain-2 1.00E-
126 
44 100 63 4 385 
P.chabaudi 
chabaudi 
AAP43630.1 Chabaupain-2 1.00E-
131 
45 100 63 3 403 
P.vivax AAT36263.1 Vivapain-2 1.00E-
171 
50 100 69 1 502 
P.knowlesi 
strain H 
XP_002259152.1 Knowlesipain-
2 
2.00E-
157 
45 99 66 5 468 
P.falciparum 
3D7 
XP_001347836.1 Falcipain-2 0 100 100 100 0 990 
P.falciparum 
3D7 
XP_001347832.1 Falcipain-2B 0 92 100 95 0 905 
P.falciparum 
3D7 
XP_001347833.1 Falcipain-3 0 55 100 70 1 538 
P.falciparum 
3D7 
XP_001348727.1 Falcipain-1 4.00E-
60 
35 62 57 8 211 
E.histolytica 
HM-1:IMSS 
XP_653254.1 cysteine 
protease 
2.00E-
36 
30 65 45 12 137 
S.scrofa NP_999057.1 Cathepsin L1 6.00E-
47 
32 65 53 10 168 
S.scrofa NP_999467.1 Cathepsin K 3.00E-
48 
34 65 53 10 172 
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S.scrofa XP_005663551.1 Cathepsin S 4.00E-
39 
32 65 49 11 146 
S.scrofa ACB59246.1 Cathepsin H 1.00E-
45 
35 62 52 13 163 
G.gallus NP_001161481.1 Cathepsin L1 3.00E-
49 
34 66 56 13 175 
G.gallus NP_990302.1 Cathepsin K 1.00E-
43 
35 56 51 12 159 
G.gallus NP_001026516.1 Cathepsin S 1.00E-
42 
30 66 52 12 156 
G.gallus AEC13302.1 Cathepsin H 8.00E-
44 
33 67 51 11 159 
G.gallus NP_001026300.1 Cathespsin O 4.00E-
30 
30 57 48 13 120 
F.catus XP_003995514.1 Cathepsin L1 2.00E-
44 
33 66 50 10 161 
F.catus XP_00399069.2 Cathepsin S 9.00E-
33 
32 53 49 9 127 
F.catus XP_006937669.1 Cathepsin F 2.00E-
33 
35 60 50 11 131 
F.catus XP_003984969.1 Cathespsin O 2.00E-
31 
33 53 50 13 125 
A.darlingi ETN64675.1 Cathepsin I 7.00E-
56 
34 66 56 7 191 
G.morsitans ABC48936.1 Cathepsin F 6.00E-
45 
32 61 53 8 159 
 
II. A summary of FP-2 and its retrieved orthologs from the NCBI database. The accession 
numbers, sequence length and the prodomain and mature domain regions are also indicated. 
 
Species name 
 
Accession 
number 
 
Common 
name  
Number of amino acids 
Total Prodomain Mature 
domain 
P.falciparum 3BWK_A Falcipain-3 243  1-243 
P.falciparum 2OUL_A cysteine 241  1-241 
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3D7 protease 
S.scrofa 8PCH_A Cathepsin H 220  1-220 
T.gondii RH 3F75_A Cathepsin L 224  99-330 
M.musculus 
(house mouse) 
4BS6_A Cathepsin S 225  1-225 
Homo sapiens 1BY8_A Procathepsin K 314  88-314 
Homo sapiens 2XU3_A Cathepsin L 220  1-241 
Homo sapiens AAH02642.1 Cathepsin S 331 1-101 102-331 
Homo sapiens AAL23961.1 Cathepsin H 335 1-103 104-335 
Homo sapiens NP_000387.1 Cathepsin K 329 1-102 103-329 
Homo sapiens AAH12612.1 Cathepsin L 333 1-101 102-333 
B.taurus NP_001029607.1 Cathepsin K 334 1-107 108-334 
B.taurus NP_001028787.1 Cathepsin S 331 1-101 102-331 
B.taurus NP_001029557.1 Cathepsin H 335 1-104 105-336 
B.taurus NP_776457.1 Cathepsin L2 334 1-101 102-334 
M.musculus AAD32136.1 Cathepsin L 334 1-101 102-334 
M.musculus NP_031828.2 Cathepsin K 329 1-102 103-329 
M.musculus AAC05781.1 Cathepsin S 340 1-109 110-340 
M.musculus AAG28508.1 Cathepsin F 462 1-235 236-462 
M.musculus AAH06878.1 Cathepsin H 333 1-101 102-333 
G.gorilla XP_004026652.1 Cathepsin K 329 1-102 103-329 
G.gorilla XP_004056662.1 Cathepsin H 335 1-103 104-33 
G.gorilla XP_004051582.1 Cathepsin W 376 1-115 116-376 
P.paniscus XP_008952375.1 Cathepsin F 368 1-141 142-368 
P.paniscus XP_003828695.1 Cathepsin W 376 1-115 116-376 
P.paniscus XP_003820654.1 Cathepsin L2 334 1-101 102-334 
P.paniscus XP_003822607.1 Cathepsin O 321 1-93 94-321 
P.troglodytes XP_001170363.1 Cathepsin W 376 1-115 116-376 
P.troglodytes XP_517502.2 Cathepsin O 318 1-90 91-318 
P.troglodytes XP_003312197.1 Cathepsin L1 278 47-278 47-278 
T.gondii ABY58967.1 TgCathepsinL 421 1-189 190-421 
L.aethiopica AEE42617.1 cysteine 
protease 
443 1-111 112-443 
L.mexicana CAA78443.1 cysteine 
protease 
443 1-111 112-443 
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L.major AFN27092.1 cysteine 
protease 
348 1-111 112-348 
L.tropica AFN27126.1 cysteine 
protease 
443 1-111 112-443 
T.brucei CAC67416.1 Rhodesiense 450 1-113 114-450 
T.cruzi AAB41118.1 Cruzipain 383 1-110 111-383 
P.berghei 
ANKA 
XP_680416.1 Berghepain-2 470 1-229 230-470 
P.yoelii yoelii 
17XNL 
XP_726900.1 Yoellipain-2 472 1-231 232-472 
P.chabaudi 
chabaudi 
AAP43630.1 Chabaupain-2 471 1-230 231-471 
P.vivax AAT36263.1 Vivapain-2 487 1-244 245-487 
P.knowlesi 
strain H 
XP_002259152.1 Knowlesipain-2 495 1-250 251-495 
P.falciparum 
3D7 
XP_001347836.1 Falcipain-2 487 1-241 242-484 
P.falciparum 
3D7 
XP_001347832.1 Falcipain-2B 482 1-239 240-482 
P.falciparum 
3D7 
XP_001347833.1 Falcipain-3 492 1-248 249-492 
P.falciparum 
3D7 
XP_001348727.1 Falcipain-1 569 1-316 317-569 
E.histolytica 
HM-1:IMSS 
XP_653254.1 cysteine 
protease 
308 1-81 82-308 
S.scrofa NP_999057.1 Cathepsin L1 334 102-334 102-334 
S.scrofa NP_999467.1 Cathepsin K 330 104-330 104-330 
S.scrofa XP_005663551.1 Cathepsin S 331 102-331 102-331 
S.scrofa ACB59246.1 Cathepsin H 297 63-297 63-297 
G.gallus NP_001161481.1 Cathepsin L1 353 121-353 121-353 
G.gallus NP_990302.1 Cathepsin K 334 108-334 108-334 
G.gallus NP_001026516.1 Cathepsin S 353 1-125 126-353 
G.gallus AEC13302.1 Cathepsin H 329 98-329 98-329 
G.gallus NP_001026300.1 Cathespsin O 321 96-321 96-321 
F.catus XP_003995514.1 Cathepsin L1 333 102-333 102-333 
F.catus XP_00399069.2 Cathepsin S 312 115-312 115-312 
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F.catus XP_006937669.1 Cathepsin F 461 235-461 235-461 
F.catus XP_003984969.1 Cathespsin O 390 163-390 163-390 
A.darlingi ETN64675.1 Cathepsin I 344 111-344 111-344 
G.morsitans ABC48936.1 Cathepsin F 471 237-471 237-471 
 
III. The retrieved sequences through reverse BLAST showing the first and second hits as 
returned by NCBI. The table indicates the protein sequence accession numbers, as well as the 
sequence identities of FP-2 and FP-3 are also indicated. 
 
 
Species name 
 
 
Accession number 
 
 
Common 
name  
REVERSE 
BLAST 
% Identity of 
sequences 
1st 
hit 
2nd 
hit 
FP-2 FP-3 
Homosapiens AAH02642.1 Cathepsin S FP-3 FP-2 32 33 
Homosapiens AAL23961.1 Cathepsin H FP-2 FP-
2B 
35 32 
Homo sapiens NP_000387.1 Cathepsin K FP-3 FP-2 34 35 
Homo sapiens AAH12612.1 Cathepsin L FP-3 FP-
2B 
32 34 
B.taurus NP_001029607.1 Cathepsin K FP-2 FP-
2B 
35 35 
B.taurus NP_001028787.1 Cathepsin S FP-3 FP-2 32 34 
B.taurus NP_001029557.1 Cathepsin H FP-2 FP-
2B 
34 34 
B.taurus NP_776457.1 Cathepsin L2 FP-3 FP-
2B 
32 34 
M.musculus AAD32136.1 Cathepsin L FP-
2B 
FP-2 32 32 
M.musculus NP_031828.2 Cathepsin K FP-2 FP-
2B 
34 36 
M.musculus AAC05781.1 Cathepsin S FP-3 FP-
2B 
32 34 
M.musculus AAG28508.1 Cathepsin F FP-3 FP-
2B 
34 36 
99 
 
M.musculus AAH06878.1 Cathepsin H FP-2 FP-
2B 
34 33 
G.gorilla XP_004026652.1 Cathepsin K FP-3 FP-2 34 35 
G.gorilla XP_004056662.1 Cathepsin H FP-2 FP-
2B 
34 32 
G.gorilla XP_004051582.1 Cathepsin W FP-2 FP-3 28 28 
P.paniscus XP_008952375.1 Cathepsin F FP-3 FP-
2B 
33 34 
P.paniscus XP_003828695.1 Cathepsin W FP-2 FP-3 29 28 
P.paniscus XP_003820654.1 Cathepsin L2 FP-
2B 
FP-3 33 33 
P.paniscus XP_003822607.1 Cathepsin O FP-2 FP-
2B 
34 32 
P.troglodytes XP_001170363.1 Cathepsin W FP-3 FP-2 29 28 
P.troglodytes XP_517502.2 Cathepsin O FP-2 FP-
2B 
34 32 
P.troglodytes XP_003312197.1 Cathepsin L1 FP-
2B 
FP-3 34 35 
T.gondii ABY58967.1 TgCathepsinL FP-
2B 
FP-2 35 38 
L.aethiopica AEE42617.1 cysteine 
protease 
FP-3 FP-2 35 38 
L.mexicana CAA78443.1 cysteine 
protease 
FP-3 FP-2 32 38 
L.major AFN27092.1 cysteine 
protease 
FP-3 FP-2 34 37 
L.tropica AFN27126.1 cysteine 
protease 
FP-3 FP-2 35 38 
T.brucei CAC67416.1 Rhodesiense FP-2 FP-
2B 
34 35 
T.cruzi AAB41118.1 Cruzipain FP-2 FP-
2B 
34 34 
P.berghei ANKA XP_680416.1 Berghepain-2 FP-3 FP-2 45 43 
P.yoelii yoelii 
17XNL 
XP_726900.1 Yoellipain-2 FP-3 FP-2 44 44 
P.chabaudi chabaudi AAP43630.1 Chabaupain-2 FP-3 FP-2 45 43 
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P.vivax AAT36263.1 Vivapain-2 FP-3 FP-2 50 55 
P.knowlesi strain H XP_002259152.1 Knowlesipain-2 FP-3 FP-2 45 50 
P.falciparum 3D7 XP_001347836.1 Falcipain-2 FP-2 FP-
2B 
100 55 
P.falciparum 3D7 XP_001347832.1 Falcipain-2B FP-
2B 
FP-2 93 54 
P.falciparum 3D7 XP_001347833.1 Falcipain-3 FP-3 FP-2 55 100 
P.falciparum 3D7 XP_001348727.1 Falcipain-1 FP-
2B 
FP-2 35 36 
E.histolytica HM-
1:IMSS 
XP_653254.1 cysteine 
protease 
FP-
2B 
FP-2 30 30 
S.scrofa NP_999057.1 Cathepsin L1 FP-
2B 
FP-3 32 34 
S.scrofa NP_999467.1 Cathepsin K FP-3 FP-2 35 36 
S.scrofa XP_005663551.1 Cathepsin S FP-3 FP-
2B 
32 34 
S.scrofa ACB59246.1 Cathepsin H FP-2 FP-
2B 
35 33 
G.gallus NP_001161481.1 Cathepsin L1 FP-3 FP-
2B 
34 35 
G.gallus NP_990302.1 Cathepsin K FP-3 FP-
2B 
35 38 
G.gallus NP_001026516.1 Cathepsin S FP-3 FP-
2B 
30 34 
G.gallus AEC13302.1 Cathepsin H FP-2 FP-
2B 
33 33 
G.gallus NP_001026300.1 Cathespsin O FP-
2B 
FP-2 30 29 
F.catus XP_003995514.1 Cathepsin L1 FP-
2B 
FP-3 33 35 
F.catus XP_00399069.2 Cathepsin S FP-3 FP-
2B 
31 35 
F.catus XP_006937669.1 Cathepsin F FP-3 FP-
2B 
35 35 
F.catus XP_003984969.1 Cathespsin O FP-
2B 
FP-2 33 30 
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A.darlingi ETN64675.1 Cathepsin I FP-2 FP-
2B 
34 35 
G.morsitans ABC48936.1 Cathepsin F FP-3 FP-
2B 
32 33 
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IV. MAFFT multiple sequence alignment which was selected as the best alignment 
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V. EXPRESSO multiple sequence alignment of the catalytic domain 
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VI. T-COFFEE multiple sequence alignment of the catalytic domain  
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VII. PROMALS3D multiple sequence alignment of the catalytic domain 
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VIII. The residues corresponding to each of the sub-sites.  
Species name Accession 
number 
Common 
name 
Sub-site 1 Sub-site 1' 
279 282 284 288 279 395 416 418 419 448 
P.falciparum 3BWK_A Falcipain-3 Q C S F A N A V S W 
P.falciparum 3D7 2OUL_A cysteine protease Q C S F V N A V S W 
S.scrofa 8PCH_A Cathepsin H Q C S F V N A V S W 
T.gondii RH 3F75_A Cathepsin L Q C S F A D G V S W 
M.musculus 
(house mouse) 
4BS6_A Cathepsin S Q C A F A N G V S W 
Homo sapiens 1BY8_A Procathepsin K Q C S F A N A V S W 
Homo sapiens 2XU3_A Cathepsin L Q C S F A N G V S W 
Homosapiens AAH02642.1 Cathepsin S Q C S F A N A V S W 
Homosapiens AAL23961.1 Cathepsin H Q C S F A N A V S W 
Homo sapiens NP_000387.1 Cathepsin K Q C A F V N A V S W 
Homo sapiens AAH12612.1 Cathepsin L Q C S F A D G V S W 
B.taurus NP_001029607.1 Cathepsin K Q C S F A D G V S W 
B.taurus NP_001028787.1 Cathepsin S Q C S F V N A V S W 
B.taurus NP_001029557.1 Cathepsin H Q C S F A D G V S W 
B.taurus NP_776457.1 Cathepsin L2 Q C S F A N G V S W 
M.musculus AAD32136.1 Cathepsin L Q C S F A D G V S W 
M.musculus NP_031828.2 Cathepsin K Q C S F A N A V S W 
M.musculus AAC05781.1 Cathepsin S Q C A F A N G V S W 
M.musculus AAG28508.1 Cathepsin F Q C S F A D A V S W 
M.musculus AAH06878.1 Cathepsin H Q C S F A N A V S W 
G.gorilla XP_004026652.1 Cathepsin K Q C S F M D S V S W 
G.gorilla XP_004056662.1 Cathepsin H Q C S F M D S V S W 
G.gorilla XP_004051582.1 Cathepsin W Q C C M A N A V S W 
P.paniscus XP_008952375.1 Cathepsin F Q C S F A N A V S W 
P.paniscus XP_003828695.1 Cathepsin W Q C C M V N A V S W 
P.paniscus XP_003820654.1 Cathepsin L2 Q C S F V N A V S W 
P.paniscus XP_003822607.1 Cathepsin O Q C S F A D A V S W 
P.troglodytes XP_001170363.1 Cathepsin W Q C S F A D G V S W 
P.troglodytes XP_517502.2 Cathepsin O Q C S F M D S V S W 
P.troglodytes XP_003312197.1 Cathepsin L1 Q C S F A D G V S W 
T.gondii ABY58967.1 TgCathepsinL Q C S F A D G V S W 
L.aethiopica AEE42617.1 cysteine protease Q C G F A N G V S W 
L.mexicana CAA78443.1 cysteine protease Q C S F A N G V S W 
L.major AFN27092.1 cysteine protease Q C S F A D G V S W 
L.tropica AFN27126.1 cysteine protease Q C S F V N A V S W 
T.brucei CAC67416.1 Rhodesiense Q C C M V N A V S W 
T.cruzi AAB41118.1 Cruzipain Q C S F A N A V S W 
P.berghei ANKA XP_680416.1 Berghepain-2 Q C S F A N G V S W 
P.yoelii yoelii 
17XNL 
XP_726900.1 Yoellipain-2 Q C S F A N G V S W 
P.chabaudi 
chabaudi 
AAP43630.1 Chabaupain-2 Q C S F A D G V S W 
P.vivax AAT36263.1 Vivapain-2 Q C A F V N A V S W 
P.knowlesi strain 
H 
XP_002259152.1 Knowlesipain-2 Q C S F A N A V S W 
P.falciparum 3D7 XP_001347836.1 Falcipain-2 Q C S F V N A V S W 
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P.falciparum 3D7 XP_001347832.1 Falcipain-2B Q C S F V N A V S W 
P.falciparum 3D7 XP_001347833.1 Falcipain-3 Q C S F V N S V S W 
P.falciparum 3D7 XP_001348727.1 Falcipain-1 Q C S F A D G V S W 
E.histolytica 
HM-1:IMSS 
XP_653254.1 cysteine protease Q C S F A N G V S W 
S.scrofa NP_999057.1 Cathepsin L1 Q C S F A D G V S W 
S.scrofa NP_999467.1 Cathepsin K Q C S F A N G V S W 
S.scrofa XP_005663551.1 Cathepsin S Q C S F A N A V S W 
S.scrofa ACB59246.1 Cathepsin H Q C S F A N C V S W 
G.gallus NP_001161481.1 Cathepsin L1 Q C S F A N A V S W 
G.gallus NP_990302.1 Cathepsin K Q C G F V N A V S W 
G.gallus NP_001026516.1 Cathepsin S Q C G F       
G.gallus AEC13302.1 Cathepsin H Q C S F V N A V S W 
G.gallus NP_001026300.1 Cathespsin O Q C S F A N A V S W 
F.catus XP_003995514.1 Cathepsin L1 Q C S F A D G V S W 
F.catus XP_00399069.2 Cathepsin S Q C S F A N G V S W 
F.catus XP_006937669.1 Cathepsin F Q C S F A D A V S W 
F.catus XP_003984969.1 Cathespsin O Q C A F A N A V S W 
A.darlingi ETN64675.1 Cathepsin I Q C A F I D G V S W 
G.morsitans ABC48936.1 Cathepsin F Q C S F A D G V S W 
 
 
Species name Accession 
number 
Common 
name 
Sub-site2 Sub-site3 
286  321 325 327 328 329 392 415  477 478 479 
P.falciparum 3BWK_A Falcipain-3  W N G Y I T S P N A F 
P.falciparum 3D7 2OUL_A cysteine 
protease 
W Y G L I N S L N A F 
S.scrofa 8PCH_A Cathepsin H W A G L P S A V Q A F 
T.gondii RH 3F75_A Cathepsin L W Q G E M N A L D A F 
M.musculus 
(house mouse) 
4BS6_A Cathepsin S W K G Y M T G V E A F 
Homo sapiens 1BY8_A Procathepsin K W D G Y M T A L N A F 
Homo sapiens 2XU3_A Cathepsin L W E G L M D A M Y A F 
Homosapiens AAH02642.1 Cathepsin S W K G F M T G V T A F 
Homosapiens AAL23961.1 Cathepsin H W  G L P S A V Q A F 
Homo sapiens NP_000387.1 Cathepsin K W D G Y M T A L N A F 
Homo sapiens AAH12612.1 Cathepsin L W E G L M D A M Y A F 
B.taurus NP_001029607.1 Cathepsin K W D G Y M T A V Q A F 
B.taurus NP_001028787.1 Cathepsin S W K G F M T G V T A F 
B.taurus NP_001029557.1 Cathepsin H W H G L P S A L N A F 
B.taurus NP_776457.1 Cathepsin L2 W Q G L M D A L N A F 
M.musculus AAD32136.1 Cathepsin L W Q G L M D A V E A F 
M.musculus NP_031828.2 Cathepsin K W Y G Y M T S V Q A F 
M.musculus AAC05781.1 Cathepsin S W K G Y M T G V E A F 
M.musculus AAG28508.1 Cathepsin F W K G L P S A L F A F 
M.musculus AAH06878.1 Cathepsin H W H G L P S A I N A Y 
G.gorilla XP_004026652.1 Cathepsin K W D G Y M T A L N A F 
G.gorilla XP_004056662.1 Cathepsin H W Y G L P S A V Q A F 
G.gorilla XP_004051582.1 Cathepsin W W D G F V W I V D A F 
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P.paniscus XP_008952375.1 Cathepsin F W K G L P S A A N A L 
P.paniscus XP_003828695.1 Cathepsin W W D G F V W T L A F L 
P.paniscus XP_003820654.1 Cathepsin L2 W Q G F M A A L Q A F 
P.paniscus XP_003822607.1 Cathepsin O W Y G S T L I I N A Y 
P.troglodytes XP_001170363.1 Cathepsin W W D G F V W I V D A F 
P.troglodytes XP_517502.2 Cathepsin O W Y G S T L I L Q A F 
P.troglodytes XP_003312197.1 Cathepsin L1 W E G L M D A L N A F 
T.gondii ABY58967.1 TgCathepsinL W Q G E M N A V D A F 
L.aethiopica AEE42617.1 cysteine 
protease 
W S G L M T A A N A L 
L.mexicana CAA78443.1 cysteine 
protease 
W N G L M L A L Q A F 
L.major AFN27092.1 cysteine 
protease 
W N G L M L A L N A F 
L.tropica AFN27126.1 cysteine 
protease 
W S G L M L A L R A F 
T.brucei CAC67416.1 Rhodesiense W F G L M D A M Y A F 
T.cruzi AAB41118.1 Cruzipain W S G L M N A L Q A F 
P.berghei ANKA XP_680416.1 Berghepain-2 W F G I L P A A Y A F 
P.yoelii yoelii 
17XNL 
XP_726900.1 Yoellipain-2 W F G I L P A A Y A F 
P.chabaudi 
chabaudi 
AAP43630.1 Chabaupain-2 W D G I L P A P L A F 
P.vivax AAT36263.1 Vivapain-2 W T G F I P S A Y A F 
P.knowlesi strain 
H 
XP_002259152.1 Knowlesipain-
2 
W N G L I P S P R A F 
P.falciparum 3D7 XP_001347836.1 Falcipain-2 W Y G L I N S L N A F 
P.falciparum 3D7 XP_001347832.1 Falcipain-2B W Y G L I N S L N A F 
P.falciparum 3D7 XP_001347833.1 Falcipain-3 W N G Y I T S P N A F 
P.falciparum 3D7 XP_001348727.1 Falcipain-1 W F G H P F N L N A F 
E.histolytica 
HM-1:IMSS 
XP_653254.1 cysteine 
protease 
W N G H P S G V Q A F 
S.scrofa NP_999057.1 Cathepsin L1 W Q G L M D A L Y S F 
S.scrofa NP_999467.1 Cathepsin K W D G Y M T A L N A F 
S.scrofa XP_005663551.1 Cathepsin S W K G F M T A L Q A F 
S.scrofa ACB59246.1 Cathepsin H W H G L P S A V R A F 
G.gallus NP_001161481.1 Cathepsin L1 W Q G L M D A M N S L 
G.gallus NP_990302.1 Cathepsin K W N G Y M T G V E A F 
G.gallus NP_001026516.1 Cathepsin S W K G F M T A I N A F 
G.gallus AEC13302.1 Cathepsin H W H G L P S A V Q A F 
G.gallus NP_001026300.1 Cathespsin O W Y G S T I T A T A L 
F.catus XP_003995514.1 Cathepsin L1 W E G L M N G L N A F 
F.catus XP_00399069.2 Cathepsin S W K G F M T A V E A F 
F.catus XP_006937669.1 Cathepsin F W K G L P S A I N A Y 
F.catus XP_003984969.1 Cathespsin O W Y G S T L V A N A L 
A.darlingi ETN64675.1 Cathepsin I W N G L M D A L N A F 
G.morsitans ABC48936.1 Cathepsin F W S G L P D G L N A Y 
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IX. Phylogenetic tree generated from the MAFFT alignment using the JTT+G substitution 
model. 
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X. Phylogenetic tree generated from the MAFFT alignment using the JTT+G+I substitution 
model. 
 
 
 
111 
 
XI. Phylogenetic tree generated from the MAFFT alignment using the rtREV+G+I substitution 
model. 
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XI. Phylogenetic tree generated from the MAFFT alignment using the WAG+G+I substitution 
model. 
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APPENDIX B: MOTIF AND PHYSICOCHEMICAL ANALYSIS 
I.  A summary of the species unique motifs according to the MEME HTML output. 
Motif number Species name Sequence 
position 
Regular expression 
 
 
Motif 41 and 64 
 
 
Trypanosoma  
 
 
95 – 115 , 236 - 
337 
 
 
 
 
 
 
Motif 43,53,56-58 
 
 
Falcipain-1 
 
 
83 – 93, 191 - 198, 
110 - 119, 1 - 6, 96 
-101 
 
 
 
 
 
 
 
 
Motif 18, 23 and 
52 
 
 
Leishmania 
 
 
212 – 232, 3 – 13, 
107 - 114 
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Motif 37, 38, 45 
and 48 
 
T,gondii 
 
110-115, 212 – 
217, 184 – 189,  9 
-14 
 
 
 
 
 
 
 
II. The script used to calculate physicochemical properties 
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III. Script used calculate the amino acid compositions 
 
 
IV. A summary of the physicochemical properties of the host, parasite and vector groups 
shown in blue, green and red backgrounds respectively. 
 
Species name 
 
Aromaticity 
 
 Gravy 
index 
 
 Instability 
index 
 
 Isoelectric 
point 
 
 Molecular 
weight 
H.sapiens-H/104-335 0.13362 -0.19698 28.47 6.91 25432 
H.sapiens-S/102-331 0.12609 -0.51087 26.56 8.29 25593 
H.sapiens-L1/102-333 0.12500 -0.53707 35.06 4.73 25635 
H.sapiens-K/103-329 0.10573 -0.58238 29.66 8.68 24969 
M.musculus-H/102-333 0.11638 -0.15000 38.00 6.99 25268 
M.musculus-L/102-334 0.10730 -0.40858 18.90 5.61 25521 
Musmusculus-S/110-340 0.12121 -0.44589 28.12 6.51 25278 
M.musculus-F/236-462 0.11894 -0.28767 34.35 6.47 25007 
M.musculus-K/103-329 0.11013 -0.51938 28.56 8.68 24882 
B.taurus-K/108-334 0.10573 -0.62115 21.37 8.80 25078 
B.taurus-S/102-331 0.11739 -0.43870 23.02 7.20 25206 
B.taurus-L2/102-334 0.11159 -0.44850 16.92 5.56 25389 
B.taurus-H/105-336 0.12069 -0.28017 26.02 8.11 25456 
G.gorilla-K/103-329 0.10573 -0.58238 29.22 8.68 24955 
G.gorilla-H/104-335 0.12931 -0.20690 27.56 7.68 25406 
G.gorilla-W/116-376 0.09962 -0.35594 37.74 8.60 29339 
P.paniscus-F/142-368 0.10573 -0.31498 38.99 7.04 24919 
P.paniscus-W/116-376 0.10345 -0.41226 36.24 8.73 29462 
P.paniscus-O/94-321 0.11842 -0.10439 25.36 6.15 25030 
P.paniscus-L2/102-334 0.11588 -0.46094 14.87 8.85 25504 
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P.troglodytes-L1/47-278 0.12500 -0.53707 35.06 4.73 25635 
P.troglodytes-W/116-376 0.10345 -0.42682 36.24 8.84 29517 
P.troglodytes-O/91-318 0.11842 -0.10439 25.36 6.15 25030 
1BY8_A/88-314 0.10573 -0.58238 29.66 8.68 24969 
4BS6_A/1-225 0.12000 -0.44667 28.43 6.11 24634 
2XU3  0.11818 -0.53000 34.69 4.68 24168 
A.darlingi-L/111-344 0.10256 -0.54060 28.26 4.65 25668 
G.morsitans-F/237-471 0.09787 -0.46979 28.34 6.07 26057 
F.catus-L1/102-333 0.11638 -0.41767 30.76 5.09 25419 
F.catus-F/235-461 0.11013 -0.23656 35.16 7.09 24909 
F.catus-S/115-312 0.11111 -0.50152 24.94 6.88 21748 
F.catus-O/163-390 0.11842 -0.14825 22.46 6.31 25091 
G.gallus-L1/121-353 0.12069 -0.59698 22.97 4.70 25599 
G.gallus-H/98-329 0.11638 -0.22888 25.35 6.23 25411 
G.gallus-O/96-321 0.12389 -0.10929 20.83 6.22 24962 
G.gallus-K/108-334 0.11062 -0.43584 39.11 9.14 24806 
Gallus-S/  0.11013 -0.34493 28.15 6.35 24778 
S.scrofa-K/104-330 0.10573 -0.61762 21.74 8.79 25053 
S.scrofa-L1/102-334 0.11159 -0.47511 20.24 5.60 25409 
S.scrofa-H/63-297 0.11915 -0.30000 26.72 6.48 25789 
S.scrofa-S/102-331 0.12609 -0.54304 29.55 8.37 25524 
8PCH_A/1-220 0.12273 -0.27500 28.04 5.81 24305 
Falcipain-1/317-569 0.12648 -0.49842 33.73 5.56 28821 
Falcipain-2A/242-484 0.11667 -0.38167 36.11 4.97 27047 
Falcipain-2B/240-482 0.11667 -0.36167 37.66 4.96 26998 
Falcipain-3/249-492 0.14108 -0.38216 24.95 4.80 27055 
Vivapain-2/245-487 0.13333 -0.27667 26.35 4.70 27017 
Knowlesipain-2/251-495 0.13223 -0.42686 35.84 4.93 27686 
Bergheipain-2/230-470 0.13808 -0.33640 34.08 4.81 27140 
Chabaupain-2/231-471 0.12971 -0.30879 49.25 4.56 26886 
Yoellipain-2/232-472 0.14226 -0.24644 37.08 4.81 27226 
Rhodesiense/114-450 0.07122 -0.14243 33.49 4.68 35574 
Cruzipain/111-383 0.13553 0.36264 26.29 4.76 29679 
L.aethiopica/112-443 0.08133 -0.18705 44.02 5.02 35531 
L.tropica/112-443 0.08434 -0.16747 48.13 5.80 35714 
L.major/112-348 0.08861 -0.09198 38.21 5.48 25454 
L.mexicana/112-443 0.08735 -0.13163 45.02 5.67 35609 
T.gondii-L/190-421 0.08621 -0.25733 54.31 4.77 25198 
E.Histolytica/82-308 0.08370 -0.44934 25.90 8.52 24486 
3BWK_A/1-243 0.14403 -0.39877 24.51 4.75 27347 
2OUL_A/1-241 0.11618 -0.38797 35.83 4.98 27156 
3F75_A/99-330 0.08929 -0.32366 55.03 4.82 24401 
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V. A summary of the p-values obtained from the Kruskal-Wallis test for the 
physicochemical properties among all the three groups. 
 
Property 
P-value 
Catalytic domain Full length sequences  Catalytic domain and full 
length sequences  
Aromaticity  0.9359 0.1965 0.6209 
Gravy index 0.0225 0.8400 0.0600 
Instability index 0.0027 0.2166 4.67E-05 
Isoelectric point 2.68E-05 0.0087 2.80E-07 
Molecular weight 0.0002 0.0019 3.17E-14 
 
